Metabotropic glutamate receptors in neurodegeneration/neuroprotection: Still a hot topic? (647 views)
Neurochem Int (ISSN: 0197-0186), 2012 Sep; 61(4): 559-565.
Export to BibTeX Export to EndNote
Paper type: Journal Article, Review,
Impact factor: 2.659, 5-year impact factor: 2.875
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-84865741390&partnerID=40&md5=c7b9926e5227d58c39c3435d44a0c0a1
Keywords: Brain Ischemia, Chronic Neurodegenerative Disorders, Metabotropic Glutamate Receptors, Neuroprotection, Neurotrophic Factors, 6 Tetrahydro 1 Methyl 4 Phenylpyridine, 2 Methyl 6 (phenylethynyl)pyridine, 3 [(2 Methyl 4 Thiazolyl)ethynyl]pyridine, 4 Amino 2 Oxabicyclo[3 1 0]hexane 4, 6 Dicarboxylic Acid, Brain Derived Neurotrophic Factor, Levodopa, Metabotropic Receptor, Metabotropic Receptor Antagonist, N Phenyl 7 (hydroxyimino)cyclopropa[b]chromen 1a Carboxamide, Nerve Growth Factor, Neurite Promoting Factor, Transforming Growth Factor Beta, Unclassified Drug, Alzheimer Disease, Amyotrophic Lateral Sclerosis, Article, Brain Damage, Dopaminergic Nerve Cell, Dyskinesia, Excitotoxicity, Human, Intoxication, Learning Disorder, Nerve Cell Lesion, Nerve Cell Necrosis, Nerve Degeneration, Neurotoxicity, Nigroneostriatal System, Nonhuman, Parkinson Disease, Priority Journal, Striatonigral Degeneration, Stroke, Allosteric Regulation, Animals, Haplorhini, Neuroprotective Agents, Neuroprotective Agents Pharmacology, Metabotropic Glutamate Metabolism, 2 Methyl 6 (phenylethynyl) Pyridine, 3 [(2 Methyl 4 Thiazolyl) Ethynyl] Pyridine, 4 Amino 2 Oxabicyclo [3 1 0] Hexane 4, N Phenyl 7 (hydroxyimino) Cyclopropa [b] Chromen 1a Carboxamide,
Affiliations:
*** IBB - CNR ***
Department of Formative Processes, University of Catania, Catania, Italy
Department of Clinical and Molecular Biomedicine, Section of Pharmacology, University of Catania, Catania 95125, Italy
I.N.M. Neuromed, Località Camerelle, 86077 Pozzilli, Italy
Department of Drug Sciences, University of Catania, Catania, Italy
I.B.B., CNR-Catania, 95125 Catania, Italy
Department of Human Physiology and Pharmacology, University of Rome, Sapienza, Piazzale Aldo Moro, 5, 00185 Rome, Italy
I. N. M. Neuromed, Localit Camerelle, 86077 Pozzilli, Italy
I. B. B., CNR-Catania, 95125 Catania, Italy
References:
Albers, G.W., Goldberg, M.P., Choi, D.W., N-methyl-d-aspartate antagonists: Ready for clinical trial in brain ischemia? (1989) Ann. Neurol., 125, pp. 398-40
Ambrosini, A., Bresciani, L., Fracchia, S., Brunello, N., Racagni, G., Metabotropic glutamate receptors negatively coupled to adenylate cyclase inhibit N-methyl-d-aspartate receptor activity and prevent neurotoxicity in mesencephalic neurons in vitro (1995) Mol. Pharmacol., 47, pp. 1057-1064
Armentero, M.T., Fancellu, R., Nappi, G., Bramanti, P., Blandini, F., Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease (2006) Neurobiol. Dis., 22, pp. 1-9
Aronica, E., Catania, M.V., Geurts, J., Yankaya, B., Troost, D., Immunohistochemical localization of group i and II metabotropic glutamate receptors in control and amyotrophic lateral sclerosis human spinal cord: Upregulation in reactive astrocytes (2001) Neuroscience, 105, pp. 509-520
Aronica, E., Gorter, J.A., Ijlst-Keizers, H., Rozemuller, A.J., Yankaya, B., Leenstra, S., Troost, D., Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: Opposite regulation of glutamate transporter proteins (2003) Eur. J. Neurosci., 17, pp. 2106-2118
Attucci, S., Carlà, V., Mannaioni, G., Moroni, F., Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges (2001) Br. J. Pharmacol., 132, pp. 799-806
Balázs, R., Miller, S., Romano, C., De Vries, A., Chun, Y., Cotman, C.W., Metabotropic glutamate receptor mGluR5 in astrocytes: Pharmacological properties and agonist regulation (1997) J. Neurochem., 69, pp. 151-163
Battaglia, G., Bruno, V., Ngomba, R.T., Di Grezia, R., Copani, A., Nicoletti, F., Selective activation of group-II metabotropic glutamate receptors is protective against excitotoxic neuronal death (1998) Eur. J. Pharmacol., 356, pp. 271-274
Battaglia, G., Busceti, C.L., Molinaro, G., Biagioni, F., Storto, M., Fornai, F., Nicoletti, F., Bruno, V., Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice (2004) J. Neurosci., 24, pp. 828-835
Battaglia, G., Molinaro, G., Riozzi, B., Storto, M., Busceti, C.L., Spinsanti, P., Bucci, D., Bruno, V., Activation of mGlu3 receptors stimulates the production of GDNF in striatal neurons (2009) PLoS One, 4 (8), p. 6591
Battaglia, G., Cannella, M., Riozzi, B., Orobello, S., Maat-Schieman, M.L., Aronica, E., Busceti, C.L., Squitieri, F., Early defect of transforming growth factor beta-1 formation in Huntington's disease (2010) J. Cell Mol. Med., 15, pp. 551-557
Battaglia, G., Riozzi, B., Molinaro, G., Bucci, D., Storto, M., Pallottino, M., Nicoletti, F., Bruno, V., Group-II mGluRs as drug targets in the treatment of amyotrophic lateral sclerosis (2011) Curr. Neuropharmacol., 9 (S1), p. 3
Berg, D., Godau, J., Trenkwalder, C., Eggert, K., Csoti, I., Storch, A., Huber, H., Gomez-Mancilla, B., AFQ056 treatment of levodopa-induced dyskinesias: Results of 2 randomized controlled trials (2011) Mov. Disord., 26, pp. 1243-1250
Black, Y.D., Xiao, D., Pellegrino, D., Kachroo, A., Brownell, A.L., Schwarzschild, M.A., Protective effect of metabotropic glutamate mGluR5 receptor elimination in a 6-hydroxydopamine model of Parkinson's disease (2010) Neurosci. Lett., 486, pp. 161-165
Bond, A., O'Neill, M.J., Hicks, C.A., Monn, J.A., Lodge, D., Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia (1998) Neuroreport, 9, pp. 1191-1193
Bond, A., Ragumoorthy, N., Monn, J.A., Hicks, C.A., Ward, M.A., Lodge, D., O'Neill, M.J., LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia (1999) Neurosci. Lett., 273, pp. 191-194
Bond, A., Jones, N.M., Hicks, C.A., Whiffin, G.M., Ward, M.A., O'Neill, M.F., Kingston, A.E., O'Neill, M.J., Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: Investigations into possible mechanism of action in vivo (2000) J. Pharmacol. Exp. Ther., 294, pp. 800-809
Brakeman, P.R., Lanahan, A.A., O'Brien, R., Roche, K., Barnes, C.A., Huganir, R.L., Worley, P.F., Homer: A protein that selectively binds metabotropic glutamate receptors (1997) Nature, 386, pp. 284-288
Brazil, D.P., Hemmings, B.A., Ten years of protein kinase B signalling: A hard Akt to follow (2001) Trends Biochem. Sci., 26, pp. 657-664
Bruno, V., Copani, A., Battaglia, G., Raffaele, R., Shinozaki, H., Nicoletti, F., Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death (1994) Eur. J. Pharmacol., 256, pp. 109-112
Bruno, V., Battaglia, G., Copani, A., Giffard, R.G., Raciti, G., Raffaele, R., Shinozaki, H., Nicoletti, F., Activation of class II or class III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration (1995) Eur. J. Neurosci., 7, pp. 1906-1913
Bruno, V., Sureda, F.X., Storto, M., Casabona, G., Caruso, A., Knopfel, T., Kuhn, R., Nicoletti, F., The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial-neuronal signaling (1997) J. Neurosci., 17, pp. 1891-1897
Buisson, A., Choi, D.W., The inhibitory mGluR agonist, S-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death (1995) Neuropharmacology, 34, pp. 1081-1087
Caraci, F., Molinaro, G., Battaglia, G., Giuffrida, M.L., Riozzi, B., Traficante, A., Bruno, V., Nicoletti, F., Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: Selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective (2011) Mol. Pharmacol., 79, pp. 618-626
Caraci, F., Spampinato, S., Sortino, M.A., Bosco, P., Battaglia, G., Bruno, V., Drago, F., Copani, A., Dysfunction of TGF-β1 signaling in Alzheimer's disease: Perspectives for neuroprotection (2011) Cell Tissue Res., , 10.1007/s00441-011-1230-6
Caraci, F., Bosco, P., Signorelli, M., Spada R., .S., Cosentino F., .I., Toscano, G., Bonforte, C., Ferri, R., The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression (2011) Eur. Neuropsychopharmacol., , doi:10.1016/j.euroneuro.2011.08.006
Choi, D.W., Glutamate neurotoxicity and diseases of the nervous system (1988) Neuron, 1, pp. 623-634
Ciccarelli, R., Di Iorio, P., Bruno, V., Battaglia, G., D'Alimonte, I., D'Onofrio, M., Nicoletti, F., Caciagli, F., Activation of A(1) adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100beta protein from cultured astrocytes (1999) Glia, 27, pp. 275-281
Cippitelli, A., Damadzic, R., Frankola, K., Goldstein, A., Thorsell, A., Singley, E., Eskay, R.L., Heilig, M., Alcohol-induced neurodegeneration, suppression of transforming growth factor-beta, and cognitive impairment in rats: Prevention by group II metabotropic glutamate receptor activation (2010) Biol. Psychiatry, 67, pp. 823-830
Conn, P.J., Battaglia, G., Marino, M.J., Nicoletti, F., Metabotropic glutamate receptors in the basal ganglia motor circuit (2005) Nat. Rev. Neurosci., 6, pp. 787-798
Copani, A., Bruno, V., Battaglia, G., Leanza, G., Pellitteri, R., Russo, A., Stanzani, S., Nicoletti, F., Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide (1995) Mol. Pharmacol., 47, pp. 890-897
Copani, A., Guccione, S., Giurato, L., Caraci, F., Calafiore, M., Sortino, M.A., Nicoletti, F., The cell cycle molecules behind neurodegeneration in Alzheimer's disease: Perspectives for drug development (2008) Curr. Med. Chem., 15, pp. 2420-2432
Corti, C., Battaglia, G., Molinaro, G., Riozzi, B., Pittaluga, A., Corsi, M., Mugnaini, M., Bruno, V., The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/ neuroprotection (2007) J. Neurosci., 27, pp. 8297-8308
Cozzi, A., Meli, E., Carlà, V., Pellicciari, R., Moroni, F., Pellegrini-Giampietro, D.E., Metabotropic glutamate 1 (mGlu1) receptor antagonists enhance GABAergic neurotransmission: A mechanism for the attenuation of post-ischemic injury and epileptiform activity? (2002) Neuropharmacology, 43, pp. 119-130
D'Antoni, S., Berretta, A., Seminara, G., Longone, P., Giuffrida-Stella, A.M., Battaglia, G., Sortino, M.A., Catania, M.V., A prolonged pharmacological blockade of type-5 metabotropic glutamate receptors protects cultured spinal cord motor neurons against excitotoxic death (2011) Neurobiol. Dis., 42, pp. 252-264
De Vry, J., Horváth, E., Schreiber, R., Neuroprotective and behavioral effects of the selective metabotropic glutamate mGlu(1) receptor antagonist BAY 36-7620 (2001) Eur. J. Pharmacol., 428, pp. 203-214
Di Liberto, V., Bonomo, A., Frinchi, M., Belluardo, N., Mudò, G., Group II metabotropic glutamate receptor activation by agonist LY379268 treatment increases the expression of brain derived neurotrophic factor in the mouse brain (2010) Neuroscience, 165, pp. 863-873
Doherty, A.J., Palmer, M.J., Henley, J.M., Collingridge, G.L., Jane, D.E., (RS)-2-Chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus (1997) Neuropharmacology, 36, pp. 265-267
D'Onofrio, M., Cuomo, L., Battaglia, G., Ngomba, R.T., Storto, M., Kingston, A.E., Orzi, F., Bruno, V., Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways (2001) J. Neurochem., 78, pp. 435-445
Duty, S., Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease (2010) Br. J. Pharmacol., 161, pp. 271-287
Emery, A.C., Pshenichkin, S., Takoudjou, G.R., Grajkowska, E., Wolfe, B.B., Wroblewski, J.T., The Protective Signaling of Metabotropic Glutamate Receptor 1 Is Mediated by Sustained, β-Arrestin-1-dependent ERK Phosphorylation (2010) J. Biol. Chem., 285, pp. 26041-26048
Emery A., .C., Hathaway, H., Pshenichkin, S., Takoudjou G., .R., Diraddo, J., Grajkowska, E., Yasuda R., .P., Wroblewski J., .T., Ligand bias at mGlu1 receptors reveals a second binding site at new endogenous agonists (2011) Curr. Neuropharmacol., 9 (S1), p. 18
Engers, D.W., Field, J.R., Le, U., Zhou, Y., Bolinger, J.D., Zamorano, R., Blobaum, A.L., Hopkins, C.R., Discovery, synthesis, and structure-activity relationship development of a series of N-(4-acetamido)phenylpicolinamides as positive allosteric modulators of metabotropic glutamate receptor 4 (mGlu(4)) with CNS exposure in rats (2011) J. Med. Chem., 54, pp. 1106-1110
Ferraguti, F., Shigemoto, R., Metabotropic glutamate receptors (2006) Cell Tissue Res., 326, pp. 483-504
Gasparini, F., Bruno, V., Battaglia, G., Lukic, S., Leonhardt, T., Inderbitzin, W., Laurie, D., Flor, P.J., (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo (1999) J. Pharmacol. Exp. Ther., 289, pp. 1678-1687
Gill, S.S., Patel, N.K., Hotton, G.R., O'Sullivan, K., McCarter, R., Bunnage, M., Brooks, D.J., Heywood, P., Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease (2003) Nat. Med., 9, pp. 589-595
Hardingham, G.E., Bading, H., Synaptic versus extra synaptic NMDA receptor signalling: Implications for neurodegenerative disorders (2010) Nat. Rev. Neurosci., 11, pp. 682-696
Henrich-Noack, P., Hatton, C.D., Reymann, K.G., The mGlu receptor ligand (S)-4C3HPG protects neurons after global ischaemia in gerbils (1998) Neuroreport, 9, pp. 985-988
Herrero, I., Miras-Portugal, M.T., Sánchez-Prieto, J., Functional switch from facilitation to inhibition in the control of glutamate release by metabotropic glutamate receptors (1998) J. Biol. Chem., 273, pp. 1951-1958
Jantzie, L.L., Talos, D.M., Selip, D.B., An, L., Jackson, M.C., Folkerth, R.D., Deng, W., Jensen, F.E., Developmental regulation of group i metabotropic glutamate receptors in the premature brain and their protective role in a rodent model of periventricular leukomalacia (2011) Neuron Glia Biol., 14, pp. 1-12
Kinon, B.J., Zhang, L., Millen, B.A., Osuntokun, O.O., Williams, J.E., Kollack-Walker, S., Jackson, K., Jarkova, N., A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia (2011) J. Clin. Psychopharmacol., 31, pp. 349-355. , the HBBI Study Group
Kohara, A., Takahashi, M., Yatsugi, S., Tamura, S., Shitaka, Y., Hayashibe, S., Kawabata, S., Okada, M., Neuroprotective effects of the selective type 1 metabotropic glutamate receptor antagonist YM-202074 in rat stroke models (2008) Brain Res., 1191, pp. 168-179
Koller, M., Urwyler, S., Novel N-methyl-d-aspartate receptor antagonists: A review of compounds patented since 2006 (2010) Exp. Opin. Ther. Pat., 20, pp. 1683-1702
Koo, S.J., Pfaff, S.L., Fine-tuning motor neuron properties: Signaling from the periphery (2002) Neuron, 35, pp. 823-826
Lam, A.G., Soriano, M.A., Monn, J.A., Schoepp, D.D., Lodge, D., McCulloch, J., Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemia (1998) Neurosci. Lett., 254, pp. 121-123
Landucci, E., Boscia, F., Gerace, E., Scartabelli, T., Cozzi, A., Moroni, F., Mannaioni, G., Pellegrini-Giampietro, D.E., Involvement of endocannabinoid signaling in the neuroprotective effects of subtype 1 metabotropic glutamate receptor antagonists in models of cerebral ischemia (2009) Int. Rev. Neurobiol., 85, pp. 337-350
Landucci, E., Scartabelli, T., Gerace, E., Moroni, F., Pellegrini-Giampietro, D.E., CB1 receptors and post-ischemic brain damage: Studies on the toxic and neuroprotective effects of cannabinoids in rat organotypic hippocampal slices (2011) Neuropharmacology, 60, pp. 674-682
Lin, L.F., Doherty, D.H., Lile, J.D., Bektesh, S., Collins, F., GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons (1993) Science, 260, pp. 1130-1132
Lipton, P., Ischemic cell death in brain neurons (1999) Physiol. Rev., 79, pp. 1431-1568
Lipton, S.A., Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond (2006) Nat. Rev. Drug Discov., 5, pp. 160-170
Loo, D.T., Copani, A., Pike, C.J., Whittemore, E.R., Walencewicz, A.J., Cotman, C.W., Apoptosis is induced by beta-amyloid in cultured central nervous system neurons (1993) Proc. Natl. Acad. Sci. USA, 90, pp. 7951-7955
Maj, M., Bruno, V., Dragic, Z., Yamamoto, R., Battaglia, G., Inderbitzin, W., Stoehr, N., Flor, P.J., (-)-PHCCC, a positive allosteric modulator of mGluR4: Characterization, mechanism of action, and neuroprotection (2003) Neuropharmacology., 45, pp. 895-906
Makarewicz, D., Duszczyk, M., Gadamski, R., Danysz, W., Łazarewicz, J.W., Neuroprotective potential of group i metabotropic glutamate receptor antagonists in two ischemic models (2006) Neurochem. Int., 48, pp. 485-490
Mannaioni, G., Marino, M.J., Valenti, O., Traynelis, S.F., Conn, P.J., Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function (2001) J. Neurosci., 21, pp. 5925-5934
Marino, M.J., Williams, Jr.D.L., O'Brien, J.A., Valenti, O., McDonald, T.P., Clements, M.K., Wang, R., Conn, P.J., Allosteric modulation of group III metabotropic glutamate receptor 4: A potential approach to Parkinson's disease treatment (2003) Proc. Natl. Acad. Sci. USA, 100, pp. 13668-13673
Masilamoni, G.J., Bogenpohl, J.W., Alagille, D., Delevich, K., Tamagnan, G., Votaw, J.R., Wichmann, T., Smith, Y., Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys (2011) Brain, 134, pp. 2057-2073
Meldrum, B., Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission (1990) Cerebrovasc. Brain Metab. Rev., 2, pp. 27-57
Meli, E., Picca, R., Attucci, S., Cozzi, A., Peruginelli, F., Moroni, F., Pellegrini-Giampietro, D.E., Activation of mGlu1 but not mGlu5 metabotropic glutamate receptors contributes to postischemic neuronal injury in vitro and in vivo (2002) Pharmacol. Biochem. Behav., 73, pp. 439-446
Mermelstein, P.G., Membrane-localised oestrogen receptor alpha and beta influence neuronal activity through activation of metabotropic glutamate receptors (2009) J. Neuroendocrinol., 21, pp. 257-262
Micevych, P.E., Mermelstein, P.G., Membrane estrogen receptors acting through metabotropic glutamate receptors: An emerging mechanism of estrogen action in brain (2008) Mol. Neurobiol., 38, pp. 66-77
Miller, S., Sehati, N., Romano, C., Cotman, C.W., Exposure of astrocytes to thrombin reduces levels of the metabotropic glutamate receptor mGluR5 (1996) J. Neurochem., 67, pp. 1435-1447
Moroni, F., Attucci, S., Cozzi, A., Meli, E., Picca, R., Scheideler, M.A., Pellicciari, R., Pellegrini-Giampietro, D.E., The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal death (2002) Neuropharmacology, 42, pp. 741-751
Moyanova, S.G., Mastroiacovo, F., Kortenska, L.V., Mitreva, R.G., Fardone, E., Santolini, I., Sobrado, M., Ngomba, R.T., Protective role for type 4 metabotropic glutamate receptors against ischemic brain damage (2011) J. Cereb. Blood Flow Metab., 31, pp. 1107-1118
Murotomi, K., Takagi, N., Takayanagi, G., Ono, M., Takeo, S., Tanonaka, K., MGluR1 antagonist decreases tyrosine phosphorylation of NMDA receptor and attenuates infarct size after transient focal cerebral ischemia (2008) J. Neurochem., 105, pp. 1625-1634
Nicoletti, F., Bockaert, J., Collingridge, G.L., Conn, P.J., Ferraguti, F., Schoepp, D.D., Wroblewski, J.T., Pin, J.P., Metabotropic glutamate receptors: From the workbench to the bedside 2011 (2011) Neuropharmacology, 60, pp. 1017-1041
Niswender, C.M., Johnson, K.A., Weaver, C.D., Jones, C.K., Xiang, Z., Luo, Q., Rodriguez, A.L., Conn, P.J., Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4 (2008) Mol. Pharmacol., 74, pp. 1345-1358
Niswender, C.M., Conn, P.J., Metabotropic glutamate receptors: Physiology, pharmacology, and disease (2010) Annu. Rev. Pharmacol. Toxicol., 50, pp. 295-322
Olney, J.W., The toxic effects of glutamate and related compounds in the retina and the brain (1982) Retina, 2, pp. 341-359
Olney, J.W., Wozniak, D.F., Farber, N.B., Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies (1997) Arch. Neurol., 54, pp. 1234-1240
Patil, S.T., Zhang, L., Martenyi, F., Lowe, S.L., Jackson, K.A., Andreev, B.V., Avedisova, A.S., Schoepp, D.D., Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial (2007) Nat. Med., 13, pp. 1102-1107
Pisani, A., Gubellini, P., Bonsi, P., Conquet, F., Picconi, B., Centonze, D., Bernardi, G., Calabresi, P., Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-d-aspartate responses in medium spiny striatal neurons (2001) Neuroscience, 106, pp. 579-587
Price, D.L., Rockenstein, E., Ubhi, K., Phung, V., MacLean-Lewis, N., Askay, D., Cartier, A., Masliah, E., Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy-implications for excitotoxicity (2010) PLoS One, 5, p. 14020
Pshenichkin, S., Dolińska, M., Klauzińska, M., Luchenko, V., Grajkowska, E., Wroblewski, J.T., Dual neurotoxic and neuroprotective role of metabotropic glutamate receptor 1 in conditions of trophic deprivation - Possible role as a dependence receptor (2008) Neuropharmacology, 55, pp. 500-508
Pshenichkin, S., Emery A., .C., Takoudjou G., .R., Diraddo, J., Hathaway, H., Grajkowska, E., Wroblewski J., .T., Neuroprotective and neurotoxic signaling of mGlu1 receptors (2011) Current Neuropharmacology., 9 (S1), p. 54
Rong, R., Ahn, J.Y., Huang, H., Nagata, E., Kalman, D., Kapp, J.A., Tu, J., Ye, K., PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis (2003) Nat. Neurosci., 6, pp. 1153-1161
Rossi, D., Brambilla, L., Valori, C.F., Roncoroni, C., Crugnola, A., Yokota, T., Bredesen, D.E., Volterra, A., Focal degeneration of astrocytes in amyotrophic lateral sclerosis (2008) Cell Death Differ., 15, pp. 1691-1700
Rothman, S.M., Olney, J.W., Glutamate and the pathophysiology of hypoxic-ischemic brain damage (1986) Ann. Neurol., 19, pp. 105-111
Rothstein, J.D., 1995-1996. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis Clin. Neurosci., 3, pp. 348-359
Schober, A., Peterziel, H., Von Bartheld, C.S., Simon, H., Krieglstein, K., Unsicker, K., GDNF applied to the MPTP-lesioned nigrostriatal system requires TGF-beta for its neuroprotective action (2007) Neurobiol. Dis., 25, pp. 378-391
Schoepp, D.D., Jane, D.E., Monn, J.A., Pharmacological agents acting at subtypes of metabotropic glutamate receptors (1999) Neuropharmacology, 38, pp. 1431-1476
Siesjö, B.K., Katsura, K., Kristián, T., The biochemical basis of cerebral ischemic damage (1995) J. Neurosurg. Anesthesiol., 7, pp. 47-52
Slevin, J.T., Gerhardt, G.A., Smith, C.D., Gash, D.M., Kryscio, R., Young, B., Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor (2005) J. Neurosurg., 102, pp. 216-222
Spampinato, S.F., Molinaro, G., Merlo, S., Iacovelli, L., Caraci, F., Battaglia, G., Nicoletti, F., Sortino, M.A., Estrogen receptors and type-1 metabotropic glutamate receptors are interdependent in protecting cortical Neurons against {beta}-amyloid toxicity (2012) Mol. Pharmacol., 81, pp. 12-20
Taylor, D.L., Diemel, L.T., Pocock, J.M., Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity (2003) J. Neurosci., 23, pp. 2150-2160
Tesseur, I., Zou, K., Esposito, L., Bard, F., Berber, E., Can, J.V., Lin, A.H., Wyss-Coray, T., Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology (2006) J. Clin. Invest., 116, pp. 3060-3069
Thomas, A.G., Liu, W., Olkowski, J.L., Tang, Z., Lin, Q., Lu, X.C., Slusher, B.S., Neuroprotection mediated by glutamate carboxypeptidase II (NAALADase) inhibition requires TGF-beta (2001) Eur. J. Pharmacol., 430, pp. 33-40
Thomsen, C., Bruno, V., Nicoletti, F., Marinozzi, M., Pellicciari, R., (2S,1′S,2′S,3′R)-2-(2′-Carboxy-3′- phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors (1996) Mol. Pharmacol., 50, pp. 6-9
Tu, J.C., Xiao, B., Yuan, J.P., Lanahan, A.A., Leoffert, K., Li, M., Linden, D.J., Worley, P.F., Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors (1998) Neuron, 21, pp. 717-726
Valenti, O., Marino, M.J., Wittmann, M., Lis, E., Dilella, A.G., Kinney, G.G., Conn, P.J., Group III metabotropic glutamate receptor-mediated modulation of the striatopallidal synapse (2003) J. Neurosci., 23, pp. 7218-7226
Werner, C.G., Scartabelli, T., Pancani, T., Landucci, E., Moroni, F., Pellegrini-Giampietro, D.E., Differential role of mGlu1 and mGlu5 receptors in rat hippocampal slice models of ischemic tolerance (2007) Eur. J. Neurosci., 25, pp. 3597-3604
Xu, W., Wong, T.P., Chery, N., Gaertner, T., Wang, Y.T., Baudry, M., Calpain-mediated mGluR1alpha truncation: A key step in excitotoxicity (2007) Neuron, 53, pp. 399-412
Yoshioka, H., Sugita, M., Kinouchi, H., Neuroprotective effects of group II metabotropic glutamate receptor agonist DCG-IV on hippocampal neurons in transient forebrain ischemia (2009) Neurosci. Lett., 461, pp. 266-270
Zhou, M., Xu, W., Liao, G., Bi, X., Baudry, M., Neuroprotection against neonatal hypoxia/ischemia-induced cerebral cell death by prevention of calpain-mediated mGluR1alpha truncation (2009) Exp. Neurol., 218, pp. 75-82
Zipfel, G.J., Lee, J.M., Choi, D.W., Reducing calcium overload in the ischemic brain (1999) N. Engl. J Med., 341, pp. 1543-1544
Albers, G. W., Goldberg, M. P., Choi, D. W., N-methyl-d-aspartate antagonists: Ready for clinical trial in brain ischemia? (1989) Ann. Neurol., 125, pp. 398-40
Armentero, M. T., Fancellu, R., Nappi, G., Bramanti, P., Blandini, F., Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease (2006) Neurobiol. Dis., 22, pp. 1-9
Attucci, S., Carl, V., Mannaioni, G., Moroni, F., Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges (2001) Br. J. Pharmacol., 132, pp. 799-806
Bal zs, R., Miller, S., Romano, C., De Vries, A., Chun, Y., Cotman, C. W., Metabotropic glutamate receptor mGluR5 in astrocytes: Pharmacological properties and agonist regulation (1997) J. Neurochem., 69, pp. 151-163
Black, Y. D., Xiao, D., Pellegrino, D., Kachroo, A., Brownell, A. L., Schwarzschild, M. A., Protective effect of metabotropic glutamate mGluR5 receptor elimination in a 6-hydroxydopamine model of Parkinson's disease (2010) Neurosci. Lett., 486, pp. 161-165
Brakeman, P. R., Lanahan, A. A., O'Brien, R., Roche, K., Barnes, C. A., Huganir, R. L., Worley, P. F., Homer: A protein that selectively binds metabotropic glutamate receptors (1997) Nature, 386, pp. 284-288
Brazil, D. P., Hemmings, B. A., Ten years of protein kinase B signalling: A hard Akt to follow (2001) Trends Biochem. Sci., 26, pp. 657-664
Choi, D. W., Glutamate neurotoxicity and diseases of the nervous system (1988) Neuron, 1, pp. 623-634
Conn, P. J., Battaglia, G., Marino, M. J., Nicoletti, F., Metabotropic glutamate receptors in the basal ganglia motor circuit (2005) Nat. Rev. Neurosci., 6, pp. 787-798
De Vry, J., Horv th, E., Schreiber, R., Neuroprotective and behavioral effects of the selective metabotropic glutamate mGlu (1) receptor antagonist BAY 36-7620 (2001) Eur. J. Pharmacol., 428, pp. 203-214
Doherty, A. J., Palmer, M. J., Henley, J. M., Collingridge, G. L., Jane, D. E., (RS) -2-Chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus (1997) Neuropharmacology, 36, pp. 265-267
Emery, A. C., Pshenichkin, S., Takoudjou, G. R., Grajkowska, E., Wolfe, B. B., Wroblewski, J. T., The Protective Signaling of Metabotropic Glutamate Receptor 1 Is Mediated by Sustained, -Arrestin-1-dependent ERK Phosphorylation (2010) J. Biol. Chem., 285, pp. 26041-26048
Emery A., . C., Hathaway, H., Pshenichkin, S., Takoudjou G., . R., Diraddo, J., Grajkowska, E., Yasuda R., . P., Wroblewski J., . T., Ligand bias at mGlu1 receptors reveals a second binding site at new endogenous agonists (2011) Curr. Neuropharmacol., 9 (S1), p. 18
Engers, D. W., Field, J. R., Le, U., Zhou, Y., Bolinger, J. D., Zamorano, R., Blobaum, A. L., Hopkins, C. R., Discovery, synthesis, and structure-activity relationship development of a series of N- (4-acetamido) phenylpicolinamides as positive allosteric modulators of metabotropic glutamate receptor 4 (mGlu (4)) with CNS exposure in rats (2011) J. Med. Chem., 54, pp. 1106-1110
Gill, S. S., Patel, N. K., Hotton, G. R., O'Sullivan, K., McCarter, R., Bunnage, M., Brooks, D. J., Heywood, P., Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease (2003) Nat. Med., 9, pp. 589-595
Hardingham, G. E., Bading, H., Synaptic versus extra synaptic NMDA receptor signalling: Implications for neurodegenerative disorders (2010) Nat. Rev. Neurosci., 11, pp. 682-696
Jantzie, L. L., Talos, D. M., Selip, D. B., An, L., Jackson, M. C., Folkerth, R. D., Deng, W., Jensen, F. E., Developmental regulation of group i metabotropic glutamate receptors in the premature brain and their protective role in a rodent model of periventricular leukomalacia (2011) Neuron Glia Biol., 14, pp. 1-12
Kinon, B. J., Zhang, L., Millen, B. A., Osuntokun, O. O., Williams, J. E., Kollack-Walker, S., Jackson, K., Jarkova, N., A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia (2011) J. Clin. Psychopharmacol., 31, pp. 349-355. , the HBBI Study Group
Koo, S. J., Pfaff, S. L., Fine-tuning motor neuron properties: Signaling from the periphery (2002) Neuron, 35, pp. 823-826
Lam, A. G., Soriano, M. A., Monn, J. A., Schoepp, D. D., Lodge, D., McCulloch, J., Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemia (1998) Neurosci. Lett., 254, pp. 121-123
Lin, L. F., Doherty, D. H., Lile, J. D., Bektesh, S., Collins, F., GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons (1993) Science, 260, pp. 1130-1132
Lipton, S. A., Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond (2006) Nat. Rev. Drug Discov., 5, pp. 160-170
Loo, D. T., Copani, A., Pike, C. J., Whittemore, E. R., Walencewicz, A. J., Cotman, C. W., Apoptosis is induced by beta-amyloid in cultured central nervous system neurons (1993) Proc. Natl. Acad. Sci. USA, 90, pp. 7951-7955
Marino, M. J., Williams, Jr. D. L., O'Brien, J. A., Valenti, O., McDonald, T. P., Clements, M. K., Wang, R., Conn, P. J., Allosteric modulation of group III metabotropic glutamate receptor 4: A potential approach to Parkinson's disease treatment (2003) Proc. Natl. Acad. Sci. USA, 100, pp. 13668-13673
Masilamoni, G. J., Bogenpohl, J. W., Alagille, D., Delevich, K., Tamagnan, G., Votaw, J. R., Wichmann, T., Smith, Y., Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys (2011) Brain, 134, pp. 2057-2073
Mermelstein, P. G., Membrane-localised oestrogen receptor alpha and beta influence neuronal activity through activation of metabotropic glutamate receptors (2009) J. Neuroendocrinol., 21, pp. 257-262
Micevych, P. E., Mermelstein, P. G., Membrane estrogen receptors acting through metabotropic glutamate receptors: An emerging mechanism of estrogen action in brain (2008) Mol. Neurobiol., 38, pp. 66-77
Moyanova, S. G., Mastroiacovo, F., Kortenska, L. V., Mitreva, R. G., Fardone, E., Santolini, I., Sobrado, M., Ngomba, R. T., Protective role for type 4 metabotropic glutamate receptors against ischemic brain damage (2011) J. Cereb. Blood Flow Metab., 31, pp. 1107-1118
Niswender, C. M., Johnson, K. A., Weaver, C. D., Jones, C. K., Xiang, Z., Luo, Q., Rodriguez, A. L., Conn, P. J., Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4 (2008) Mol. Pharmacol., 74, pp. 1345-1358
Niswender, C. M., Conn, P. J., Metabotropic glutamate receptors: Physiology, pharmacology, and disease (2010) Annu. Rev. Pharmacol. Toxicol., 50, pp. 295-322
Olney, J. W., The toxic effects of glutamate and related compounds in the retina and the brain (1982) Retina, 2, pp. 341-359
Olney, J. W., Wozniak, D. F., Farber, N. B., Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies (1997) Arch. Neurol., 54, pp. 1234-1240
Patil, S. T., Zhang, L., Martenyi, F., Lowe, S. L., Jackson, K. A., Andreev, B. V., Avedisova, A. S., Schoepp, D. D., Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial (2007) Nat. Med., 13, pp. 1102-1107
Price, D. L., Rockenstein, E., Ubhi, K., Phung, V., MacLean-Lewis, N., Askay, D., Cartier, A., Masliah, E., Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy-implications for excitotoxicity (2010) PLoS One, 5, p. 14020
Rong, R., Ahn, J. Y., Huang, H., Nagata, E., Kalman, D., Kapp, J. A., Tu, J., Ye, K., PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis (2003) Nat. Neurosci., 6, pp. 1153-1161
Rothman, S. M., Olney, J. W., Glutamate and the pathophysiology of hypoxic-ischemic brain damage (1986) Ann. Neurol., 19, pp. 105-111
Rothstein, J. D., 1995-1996. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis Clin. Neurosci., 3, pp. 348-359
Schoepp, D. D., Jane, D. E., Monn, J. A., Pharmacological agents acting at subtypes of metabotropic glutamate receptors (1999) Neuropharmacology, 38, pp. 1431-1476
Siesj, B. K., Katsura, K., Kristi n, T., The biochemical basis of cerebral ischemic damage (1995) J. Neurosurg. Anesthesiol., 7, pp. 47-52
Slevin, J. T., Gerhardt, G. A., Smith, C. D., Gash, D. M., Kryscio, R., Young, B., Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor (2005) J. Neurosurg., 102, pp. 216-222
Spampinato, S. F., Molinaro, G., Merlo, S., Iacovelli, L., Caraci, F., Battaglia, G., Nicoletti, F., Sortino, M. A., Estrogen receptors and type-1 metabotropic glutamate receptors are interdependent in protecting cortical Neurons against {beta} -amyloid toxicity (2012) Mol. Pharmacol., 81, pp. 12-20
Taylor, D. L., Diemel, L. T., Pocock, J. M., Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity (2003) J. Neurosci., 23, pp. 2150-2160
Thomas, A. G., Liu, W., Olkowski, J. L., Tang, Z., Lin, Q., Lu, X. C., Slusher, B. S., Neuroprotection mediated by glutamate carboxypeptidase II (NAALADase) inhibition requires TGF-beta (2001) Eur. J. Pharmacol., 430, pp. 33-40
Tu, J. C., Xiao, B., Yuan, J. P., Lanahan, A. A., Leoffert, K., Li, M., Linden, D. J., Worley, P. F., Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors (1998) Neuron, 21, pp. 717-726
Werner, C. G., Scartabelli, T., Pancani, T., Landucci, E., Moroni, F., Pellegrini-Giampietro, D. E., Differential role of mGlu1 and mGlu5 receptors in rat hippocampal slice models of ischemic tolerance (2007) Eur. J. Neurosci., 25, pp. 3597-3604
Xu, W., Wong, T. P., Chery, N., Gaertner, T., Wang, Y. T., Baudry, M., Calpain-mediated mGluR1alpha truncation: A key step in excitotoxicity (2007) Neuron, 53, pp. 399-412
Zipfel, G. J., Lee, J. M., Choi, D. W., Reducing calcium overload in the ischemic brain (1999) N. Engl. J Med., 341, pp. 1543-1544
Neurochem Int (ISSN: 0197-0186), 2012 Sep; 61(4): 559-565.
Export to BibTeX Export to EndNote
Paper type: Journal Article, Review,
Impact factor: 2.659, 5-year impact factor: 2.875
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-84865741390&partnerID=40&md5=c7b9926e5227d58c39c3435d44a0c0a1
Keywords: Brain Ischemia, Chronic Neurodegenerative Disorders, Metabotropic Glutamate Receptors, Neuroprotection, Neurotrophic Factors, 6 Tetrahydro 1 Methyl 4 Phenylpyridine, 2 Methyl 6 (phenylethynyl)pyridine, 3 [(2 Methyl 4 Thiazolyl)ethynyl]pyridine, 4 Amino 2 Oxabicyclo[3 1 0]hexane 4, 6 Dicarboxylic Acid, Brain Derived Neurotrophic Factor, Levodopa, Metabotropic Receptor, Metabotropic Receptor Antagonist, N Phenyl 7 (hydroxyimino)cyclopropa[b]chromen 1a Carboxamide, Nerve Growth Factor, Neurite Promoting Factor, Transforming Growth Factor Beta, Unclassified Drug, Alzheimer Disease, Amyotrophic Lateral Sclerosis, Article, Brain Damage, Dopaminergic Nerve Cell, Dyskinesia, Excitotoxicity, Human, Intoxication, Learning Disorder, Nerve Cell Lesion, Nerve Cell Necrosis, Nerve Degeneration, Neurotoxicity, Nigroneostriatal System, Nonhuman, Parkinson Disease, Priority Journal, Striatonigral Degeneration, Stroke, Allosteric Regulation, Animals, Haplorhini, Neuroprotective Agents, Neuroprotective Agents Pharmacology, Metabotropic Glutamate Metabolism, 2 Methyl 6 (phenylethynyl) Pyridine, 3 [(2 Methyl 4 Thiazolyl) Ethynyl] Pyridine, 4 Amino 2 Oxabicyclo [3 1 0] Hexane 4, N Phenyl 7 (hydroxyimino) Cyclopropa [b] Chromen 1a Carboxamide,
Affiliations:
*** IBB - CNR ***
Department of Formative Processes, University of Catania, Catania, Italy
Department of Clinical and Molecular Biomedicine, Section of Pharmacology, University of Catania, Catania 95125, Italy
I.N.M. Neuromed, Località Camerelle, 86077 Pozzilli, Italy
Department of Drug Sciences, University of Catania, Catania, Italy
I.B.B., CNR-Catania, 95125 Catania, Italy
Department of Human Physiology and Pharmacology, University of Rome, Sapienza, Piazzale Aldo Moro, 5, 00185 Rome, Italy
I. N. M. Neuromed, Localit Camerelle, 86077 Pozzilli, Italy
I. B. B., CNR-Catania, 95125 Catania, Italy
References:
Albers, G.W., Goldberg, M.P., Choi, D.W., N-methyl-d-aspartate antagonists: Ready for clinical trial in brain ischemia? (1989) Ann. Neurol., 125, pp. 398-40
Ambrosini, A., Bresciani, L., Fracchia, S., Brunello, N., Racagni, G., Metabotropic glutamate receptors negatively coupled to adenylate cyclase inhibit N-methyl-d-aspartate receptor activity and prevent neurotoxicity in mesencephalic neurons in vitro (1995) Mol. Pharmacol., 47, pp. 1057-1064
Armentero, M.T., Fancellu, R., Nappi, G., Bramanti, P., Blandini, F., Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease (2006) Neurobiol. Dis., 22, pp. 1-9
Aronica, E., Catania, M.V., Geurts, J., Yankaya, B., Troost, D., Immunohistochemical localization of group i and II metabotropic glutamate receptors in control and amyotrophic lateral sclerosis human spinal cord: Upregulation in reactive astrocytes (2001) Neuroscience, 105, pp. 509-520
Aronica, E., Gorter, J.A., Ijlst-Keizers, H., Rozemuller, A.J., Yankaya, B., Leenstra, S., Troost, D., Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: Opposite regulation of glutamate transporter proteins (2003) Eur. J. Neurosci., 17, pp. 2106-2118
Attucci, S., Carlà, V., Mannaioni, G., Moroni, F., Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges (2001) Br. J. Pharmacol., 132, pp. 799-806
Balázs, R., Miller, S., Romano, C., De Vries, A., Chun, Y., Cotman, C.W., Metabotropic glutamate receptor mGluR5 in astrocytes: Pharmacological properties and agonist regulation (1997) J. Neurochem., 69, pp. 151-163
Battaglia, G., Bruno, V., Ngomba, R.T., Di Grezia, R., Copani, A., Nicoletti, F., Selective activation of group-II metabotropic glutamate receptors is protective against excitotoxic neuronal death (1998) Eur. J. Pharmacol., 356, pp. 271-274
Battaglia, G., Busceti, C.L., Molinaro, G., Biagioni, F., Storto, M., Fornai, F., Nicoletti, F., Bruno, V., Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice (2004) J. Neurosci., 24, pp. 828-835
Battaglia, G., Molinaro, G., Riozzi, B., Storto, M., Busceti, C.L., Spinsanti, P., Bucci, D., Bruno, V., Activation of mGlu3 receptors stimulates the production of GDNF in striatal neurons (2009) PLoS One, 4 (8), p. 6591
Battaglia, G., Cannella, M., Riozzi, B., Orobello, S., Maat-Schieman, M.L., Aronica, E., Busceti, C.L., Squitieri, F., Early defect of transforming growth factor beta-1 formation in Huntington's disease (2010) J. Cell Mol. Med., 15, pp. 551-557
Battaglia, G., Riozzi, B., Molinaro, G., Bucci, D., Storto, M., Pallottino, M., Nicoletti, F., Bruno, V., Group-II mGluRs as drug targets in the treatment of amyotrophic lateral sclerosis (2011) Curr. Neuropharmacol., 9 (S1), p. 3
Berg, D., Godau, J., Trenkwalder, C., Eggert, K., Csoti, I., Storch, A., Huber, H., Gomez-Mancilla, B., AFQ056 treatment of levodopa-induced dyskinesias: Results of 2 randomized controlled trials (2011) Mov. Disord., 26, pp. 1243-1250
Black, Y.D., Xiao, D., Pellegrino, D., Kachroo, A., Brownell, A.L., Schwarzschild, M.A., Protective effect of metabotropic glutamate mGluR5 receptor elimination in a 6-hydroxydopamine model of Parkinson's disease (2010) Neurosci. Lett., 486, pp. 161-165
Bond, A., O'Neill, M.J., Hicks, C.A., Monn, J.A., Lodge, D., Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia (1998) Neuroreport, 9, pp. 1191-1193
Bond, A., Ragumoorthy, N., Monn, J.A., Hicks, C.A., Ward, M.A., Lodge, D., O'Neill, M.J., LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia (1999) Neurosci. Lett., 273, pp. 191-194
Bond, A., Jones, N.M., Hicks, C.A., Whiffin, G.M., Ward, M.A., O'Neill, M.F., Kingston, A.E., O'Neill, M.J., Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: Investigations into possible mechanism of action in vivo (2000) J. Pharmacol. Exp. Ther., 294, pp. 800-809
Brakeman, P.R., Lanahan, A.A., O'Brien, R., Roche, K., Barnes, C.A., Huganir, R.L., Worley, P.F., Homer: A protein that selectively binds metabotropic glutamate receptors (1997) Nature, 386, pp. 284-288
Brazil, D.P., Hemmings, B.A., Ten years of protein kinase B signalling: A hard Akt to follow (2001) Trends Biochem. Sci., 26, pp. 657-664
Bruno, V., Copani, A., Battaglia, G., Raffaele, R., Shinozaki, H., Nicoletti, F., Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death (1994) Eur. J. Pharmacol., 256, pp. 109-112
Bruno, V., Battaglia, G., Copani, A., Giffard, R.G., Raciti, G., Raffaele, R., Shinozaki, H., Nicoletti, F., Activation of class II or class III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration (1995) Eur. J. Neurosci., 7, pp. 1906-1913
Bruno, V., Sureda, F.X., Storto, M., Casabona, G., Caruso, A., Knopfel, T., Kuhn, R., Nicoletti, F., The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial-neuronal signaling (1997) J. Neurosci., 17, pp. 1891-1897
Buisson, A., Choi, D.W., The inhibitory mGluR agonist, S-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death (1995) Neuropharmacology, 34, pp. 1081-1087
Caraci, F., Molinaro, G., Battaglia, G., Giuffrida, M.L., Riozzi, B., Traficante, A., Bruno, V., Nicoletti, F., Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: Selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective (2011) Mol. Pharmacol., 79, pp. 618-626
Caraci, F., Spampinato, S., Sortino, M.A., Bosco, P., Battaglia, G., Bruno, V., Drago, F., Copani, A., Dysfunction of TGF-β1 signaling in Alzheimer's disease: Perspectives for neuroprotection (2011) Cell Tissue Res., , 10.1007/s00441-011-1230-6
Caraci, F., Bosco, P., Signorelli, M., Spada R., .S., Cosentino F., .I., Toscano, G., Bonforte, C., Ferri, R., The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression (2011) Eur. Neuropsychopharmacol., , doi:10.1016/j.euroneuro.2011.08.006
Choi, D.W., Glutamate neurotoxicity and diseases of the nervous system (1988) Neuron, 1, pp. 623-634
Ciccarelli, R., Di Iorio, P., Bruno, V., Battaglia, G., D'Alimonte, I., D'Onofrio, M., Nicoletti, F., Caciagli, F., Activation of A(1) adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100beta protein from cultured astrocytes (1999) Glia, 27, pp. 275-281
Cippitelli, A., Damadzic, R., Frankola, K., Goldstein, A., Thorsell, A., Singley, E., Eskay, R.L., Heilig, M., Alcohol-induced neurodegeneration, suppression of transforming growth factor-beta, and cognitive impairment in rats: Prevention by group II metabotropic glutamate receptor activation (2010) Biol. Psychiatry, 67, pp. 823-830
Conn, P.J., Battaglia, G., Marino, M.J., Nicoletti, F., Metabotropic glutamate receptors in the basal ganglia motor circuit (2005) Nat. Rev. Neurosci., 6, pp. 787-798
Copani, A., Bruno, V., Battaglia, G., Leanza, G., Pellitteri, R., Russo, A., Stanzani, S., Nicoletti, F., Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide (1995) Mol. Pharmacol., 47, pp. 890-897
Copani, A., Guccione, S., Giurato, L., Caraci, F., Calafiore, M., Sortino, M.A., Nicoletti, F., The cell cycle molecules behind neurodegeneration in Alzheimer's disease: Perspectives for drug development (2008) Curr. Med. Chem., 15, pp. 2420-2432
Corti, C., Battaglia, G., Molinaro, G., Riozzi, B., Pittaluga, A., Corsi, M., Mugnaini, M., Bruno, V., The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/ neuroprotection (2007) J. Neurosci., 27, pp. 8297-8308
Cozzi, A., Meli, E., Carlà, V., Pellicciari, R., Moroni, F., Pellegrini-Giampietro, D.E., Metabotropic glutamate 1 (mGlu1) receptor antagonists enhance GABAergic neurotransmission: A mechanism for the attenuation of post-ischemic injury and epileptiform activity? (2002) Neuropharmacology, 43, pp. 119-130
D'Antoni, S., Berretta, A., Seminara, G., Longone, P., Giuffrida-Stella, A.M., Battaglia, G., Sortino, M.A., Catania, M.V., A prolonged pharmacological blockade of type-5 metabotropic glutamate receptors protects cultured spinal cord motor neurons against excitotoxic death (2011) Neurobiol. Dis., 42, pp. 252-264
De Vry, J., Horváth, E., Schreiber, R., Neuroprotective and behavioral effects of the selective metabotropic glutamate mGlu(1) receptor antagonist BAY 36-7620 (2001) Eur. J. Pharmacol., 428, pp. 203-214
Di Liberto, V., Bonomo, A., Frinchi, M., Belluardo, N., Mudò, G., Group II metabotropic glutamate receptor activation by agonist LY379268 treatment increases the expression of brain derived neurotrophic factor in the mouse brain (2010) Neuroscience, 165, pp. 863-873
Doherty, A.J., Palmer, M.J., Henley, J.M., Collingridge, G.L., Jane, D.E., (RS)-2-Chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus (1997) Neuropharmacology, 36, pp. 265-267
D'Onofrio, M., Cuomo, L., Battaglia, G., Ngomba, R.T., Storto, M., Kingston, A.E., Orzi, F., Bruno, V., Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways (2001) J. Neurochem., 78, pp. 435-445
Duty, S., Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease (2010) Br. J. Pharmacol., 161, pp. 271-287
Emery, A.C., Pshenichkin, S., Takoudjou, G.R., Grajkowska, E., Wolfe, B.B., Wroblewski, J.T., The Protective Signaling of Metabotropic Glutamate Receptor 1 Is Mediated by Sustained, β-Arrestin-1-dependent ERK Phosphorylation (2010) J. Biol. Chem., 285, pp. 26041-26048
Emery A., .C., Hathaway, H., Pshenichkin, S., Takoudjou G., .R., Diraddo, J., Grajkowska, E., Yasuda R., .P., Wroblewski J., .T., Ligand bias at mGlu1 receptors reveals a second binding site at new endogenous agonists (2011) Curr. Neuropharmacol., 9 (S1), p. 18
Engers, D.W., Field, J.R., Le, U., Zhou, Y., Bolinger, J.D., Zamorano, R., Blobaum, A.L., Hopkins, C.R., Discovery, synthesis, and structure-activity relationship development of a series of N-(4-acetamido)phenylpicolinamides as positive allosteric modulators of metabotropic glutamate receptor 4 (mGlu(4)) with CNS exposure in rats (2011) J. Med. Chem., 54, pp. 1106-1110
Ferraguti, F., Shigemoto, R., Metabotropic glutamate receptors (2006) Cell Tissue Res., 326, pp. 483-504
Gasparini, F., Bruno, V., Battaglia, G., Lukic, S., Leonhardt, T., Inderbitzin, W., Laurie, D., Flor, P.J., (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo (1999) J. Pharmacol. Exp. Ther., 289, pp. 1678-1687
Gill, S.S., Patel, N.K., Hotton, G.R., O'Sullivan, K., McCarter, R., Bunnage, M., Brooks, D.J., Heywood, P., Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease (2003) Nat. Med., 9, pp. 589-595
Hardingham, G.E., Bading, H., Synaptic versus extra synaptic NMDA receptor signalling: Implications for neurodegenerative disorders (2010) Nat. Rev. Neurosci., 11, pp. 682-696
Henrich-Noack, P., Hatton, C.D., Reymann, K.G., The mGlu receptor ligand (S)-4C3HPG protects neurons after global ischaemia in gerbils (1998) Neuroreport, 9, pp. 985-988
Herrero, I., Miras-Portugal, M.T., Sánchez-Prieto, J., Functional switch from facilitation to inhibition in the control of glutamate release by metabotropic glutamate receptors (1998) J. Biol. Chem., 273, pp. 1951-1958
Jantzie, L.L., Talos, D.M., Selip, D.B., An, L., Jackson, M.C., Folkerth, R.D., Deng, W., Jensen, F.E., Developmental regulation of group i metabotropic glutamate receptors in the premature brain and their protective role in a rodent model of periventricular leukomalacia (2011) Neuron Glia Biol., 14, pp. 1-12
Kinon, B.J., Zhang, L., Millen, B.A., Osuntokun, O.O., Williams, J.E., Kollack-Walker, S., Jackson, K., Jarkova, N., A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia (2011) J. Clin. Psychopharmacol., 31, pp. 349-355. , the HBBI Study Group
Kohara, A., Takahashi, M., Yatsugi, S., Tamura, S., Shitaka, Y., Hayashibe, S., Kawabata, S., Okada, M., Neuroprotective effects of the selective type 1 metabotropic glutamate receptor antagonist YM-202074 in rat stroke models (2008) Brain Res., 1191, pp. 168-179
Koller, M., Urwyler, S., Novel N-methyl-d-aspartate receptor antagonists: A review of compounds patented since 2006 (2010) Exp. Opin. Ther. Pat., 20, pp. 1683-1702
Koo, S.J., Pfaff, S.L., Fine-tuning motor neuron properties: Signaling from the periphery (2002) Neuron, 35, pp. 823-826
Lam, A.G., Soriano, M.A., Monn, J.A., Schoepp, D.D., Lodge, D., McCulloch, J., Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemia (1998) Neurosci. Lett., 254, pp. 121-123
Landucci, E., Boscia, F., Gerace, E., Scartabelli, T., Cozzi, A., Moroni, F., Mannaioni, G., Pellegrini-Giampietro, D.E., Involvement of endocannabinoid signaling in the neuroprotective effects of subtype 1 metabotropic glutamate receptor antagonists in models of cerebral ischemia (2009) Int. Rev. Neurobiol., 85, pp. 337-350
Landucci, E., Scartabelli, T., Gerace, E., Moroni, F., Pellegrini-Giampietro, D.E., CB1 receptors and post-ischemic brain damage: Studies on the toxic and neuroprotective effects of cannabinoids in rat organotypic hippocampal slices (2011) Neuropharmacology, 60, pp. 674-682
Lin, L.F., Doherty, D.H., Lile, J.D., Bektesh, S., Collins, F., GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons (1993) Science, 260, pp. 1130-1132
Lipton, P., Ischemic cell death in brain neurons (1999) Physiol. Rev., 79, pp. 1431-1568
Lipton, S.A., Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond (2006) Nat. Rev. Drug Discov., 5, pp. 160-170
Loo, D.T., Copani, A., Pike, C.J., Whittemore, E.R., Walencewicz, A.J., Cotman, C.W., Apoptosis is induced by beta-amyloid in cultured central nervous system neurons (1993) Proc. Natl. Acad. Sci. USA, 90, pp. 7951-7955
Maj, M., Bruno, V., Dragic, Z., Yamamoto, R., Battaglia, G., Inderbitzin, W., Stoehr, N., Flor, P.J., (-)-PHCCC, a positive allosteric modulator of mGluR4: Characterization, mechanism of action, and neuroprotection (2003) Neuropharmacology., 45, pp. 895-906
Makarewicz, D., Duszczyk, M., Gadamski, R., Danysz, W., Łazarewicz, J.W., Neuroprotective potential of group i metabotropic glutamate receptor antagonists in two ischemic models (2006) Neurochem. Int., 48, pp. 485-490
Mannaioni, G., Marino, M.J., Valenti, O., Traynelis, S.F., Conn, P.J., Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function (2001) J. Neurosci., 21, pp. 5925-5934
Marino, M.J., Williams, Jr.D.L., O'Brien, J.A., Valenti, O., McDonald, T.P., Clements, M.K., Wang, R., Conn, P.J., Allosteric modulation of group III metabotropic glutamate receptor 4: A potential approach to Parkinson's disease treatment (2003) Proc. Natl. Acad. Sci. USA, 100, pp. 13668-13673
Masilamoni, G.J., Bogenpohl, J.W., Alagille, D., Delevich, K., Tamagnan, G., Votaw, J.R., Wichmann, T., Smith, Y., Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys (2011) Brain, 134, pp. 2057-2073
Meldrum, B., Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission (1990) Cerebrovasc. Brain Metab. Rev., 2, pp. 27-57
Meli, E., Picca, R., Attucci, S., Cozzi, A., Peruginelli, F., Moroni, F., Pellegrini-Giampietro, D.E., Activation of mGlu1 but not mGlu5 metabotropic glutamate receptors contributes to postischemic neuronal injury in vitro and in vivo (2002) Pharmacol. Biochem. Behav., 73, pp. 439-446
Mermelstein, P.G., Membrane-localised oestrogen receptor alpha and beta influence neuronal activity through activation of metabotropic glutamate receptors (2009) J. Neuroendocrinol., 21, pp. 257-262
Micevych, P.E., Mermelstein, P.G., Membrane estrogen receptors acting through metabotropic glutamate receptors: An emerging mechanism of estrogen action in brain (2008) Mol. Neurobiol., 38, pp. 66-77
Miller, S., Sehati, N., Romano, C., Cotman, C.W., Exposure of astrocytes to thrombin reduces levels of the metabotropic glutamate receptor mGluR5 (1996) J. Neurochem., 67, pp. 1435-1447
Moroni, F., Attucci, S., Cozzi, A., Meli, E., Picca, R., Scheideler, M.A., Pellicciari, R., Pellegrini-Giampietro, D.E., The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal death (2002) Neuropharmacology, 42, pp. 741-751
Moyanova, S.G., Mastroiacovo, F., Kortenska, L.V., Mitreva, R.G., Fardone, E., Santolini, I., Sobrado, M., Ngomba, R.T., Protective role for type 4 metabotropic glutamate receptors against ischemic brain damage (2011) J. Cereb. Blood Flow Metab., 31, pp. 1107-1118
Murotomi, K., Takagi, N., Takayanagi, G., Ono, M., Takeo, S., Tanonaka, K., MGluR1 antagonist decreases tyrosine phosphorylation of NMDA receptor and attenuates infarct size after transient focal cerebral ischemia (2008) J. Neurochem., 105, pp. 1625-1634
Nicoletti, F., Bockaert, J., Collingridge, G.L., Conn, P.J., Ferraguti, F., Schoepp, D.D., Wroblewski, J.T., Pin, J.P., Metabotropic glutamate receptors: From the workbench to the bedside 2011 (2011) Neuropharmacology, 60, pp. 1017-1041
Niswender, C.M., Johnson, K.A., Weaver, C.D., Jones, C.K., Xiang, Z., Luo, Q., Rodriguez, A.L., Conn, P.J., Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4 (2008) Mol. Pharmacol., 74, pp. 1345-1358
Niswender, C.M., Conn, P.J., Metabotropic glutamate receptors: Physiology, pharmacology, and disease (2010) Annu. Rev. Pharmacol. Toxicol., 50, pp. 295-322
Olney, J.W., The toxic effects of glutamate and related compounds in the retina and the brain (1982) Retina, 2, pp. 341-359
Olney, J.W., Wozniak, D.F., Farber, N.B., Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies (1997) Arch. Neurol., 54, pp. 1234-1240
Patil, S.T., Zhang, L., Martenyi, F., Lowe, S.L., Jackson, K.A., Andreev, B.V., Avedisova, A.S., Schoepp, D.D., Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial (2007) Nat. Med., 13, pp. 1102-1107
Pisani, A., Gubellini, P., Bonsi, P., Conquet, F., Picconi, B., Centonze, D., Bernardi, G., Calabresi, P., Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-d-aspartate responses in medium spiny striatal neurons (2001) Neuroscience, 106, pp. 579-587
Price, D.L., Rockenstein, E., Ubhi, K., Phung, V., MacLean-Lewis, N., Askay, D., Cartier, A., Masliah, E., Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy-implications for excitotoxicity (2010) PLoS One, 5, p. 14020
Pshenichkin, S., Dolińska, M., Klauzińska, M., Luchenko, V., Grajkowska, E., Wroblewski, J.T., Dual neurotoxic and neuroprotective role of metabotropic glutamate receptor 1 in conditions of trophic deprivation - Possible role as a dependence receptor (2008) Neuropharmacology, 55, pp. 500-508
Pshenichkin, S., Emery A., .C., Takoudjou G., .R., Diraddo, J., Hathaway, H., Grajkowska, E., Wroblewski J., .T., Neuroprotective and neurotoxic signaling of mGlu1 receptors (2011) Current Neuropharmacology., 9 (S1), p. 54
Rong, R., Ahn, J.Y., Huang, H., Nagata, E., Kalman, D., Kapp, J.A., Tu, J., Ye, K., PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis (2003) Nat. Neurosci., 6, pp. 1153-1161
Rossi, D., Brambilla, L., Valori, C.F., Roncoroni, C., Crugnola, A., Yokota, T., Bredesen, D.E., Volterra, A., Focal degeneration of astrocytes in amyotrophic lateral sclerosis (2008) Cell Death Differ., 15, pp. 1691-1700
Rothman, S.M., Olney, J.W., Glutamate and the pathophysiology of hypoxic-ischemic brain damage (1986) Ann. Neurol., 19, pp. 105-111
Rothstein, J.D., 1995-1996. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis Clin. Neurosci., 3, pp. 348-359
Schober, A., Peterziel, H., Von Bartheld, C.S., Simon, H., Krieglstein, K., Unsicker, K., GDNF applied to the MPTP-lesioned nigrostriatal system requires TGF-beta for its neuroprotective action (2007) Neurobiol. Dis., 25, pp. 378-391
Schoepp, D.D., Jane, D.E., Monn, J.A., Pharmacological agents acting at subtypes of metabotropic glutamate receptors (1999) Neuropharmacology, 38, pp. 1431-1476
Siesjö, B.K., Katsura, K., Kristián, T., The biochemical basis of cerebral ischemic damage (1995) J. Neurosurg. Anesthesiol., 7, pp. 47-52
Slevin, J.T., Gerhardt, G.A., Smith, C.D., Gash, D.M., Kryscio, R., Young, B., Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor (2005) J. Neurosurg., 102, pp. 216-222
Spampinato, S.F., Molinaro, G., Merlo, S., Iacovelli, L., Caraci, F., Battaglia, G., Nicoletti, F., Sortino, M.A., Estrogen receptors and type-1 metabotropic glutamate receptors are interdependent in protecting cortical Neurons against {beta}-amyloid toxicity (2012) Mol. Pharmacol., 81, pp. 12-20
Taylor, D.L., Diemel, L.T., Pocock, J.M., Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity (2003) J. Neurosci., 23, pp. 2150-2160
Tesseur, I., Zou, K., Esposito, L., Bard, F., Berber, E., Can, J.V., Lin, A.H., Wyss-Coray, T., Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology (2006) J. Clin. Invest., 116, pp. 3060-3069
Thomas, A.G., Liu, W., Olkowski, J.L., Tang, Z., Lin, Q., Lu, X.C., Slusher, B.S., Neuroprotection mediated by glutamate carboxypeptidase II (NAALADase) inhibition requires TGF-beta (2001) Eur. J. Pharmacol., 430, pp. 33-40
Thomsen, C., Bruno, V., Nicoletti, F., Marinozzi, M., Pellicciari, R., (2S,1′S,2′S,3′R)-2-(2′-Carboxy-3′- phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors (1996) Mol. Pharmacol., 50, pp. 6-9
Tu, J.C., Xiao, B., Yuan, J.P., Lanahan, A.A., Leoffert, K., Li, M., Linden, D.J., Worley, P.F., Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors (1998) Neuron, 21, pp. 717-726
Valenti, O., Marino, M.J., Wittmann, M., Lis, E., Dilella, A.G., Kinney, G.G., Conn, P.J., Group III metabotropic glutamate receptor-mediated modulation of the striatopallidal synapse (2003) J. Neurosci., 23, pp. 7218-7226
Werner, C.G., Scartabelli, T., Pancani, T., Landucci, E., Moroni, F., Pellegrini-Giampietro, D.E., Differential role of mGlu1 and mGlu5 receptors in rat hippocampal slice models of ischemic tolerance (2007) Eur. J. Neurosci., 25, pp. 3597-3604
Xu, W., Wong, T.P., Chery, N., Gaertner, T., Wang, Y.T., Baudry, M., Calpain-mediated mGluR1alpha truncation: A key step in excitotoxicity (2007) Neuron, 53, pp. 399-412
Yoshioka, H., Sugita, M., Kinouchi, H., Neuroprotective effects of group II metabotropic glutamate receptor agonist DCG-IV on hippocampal neurons in transient forebrain ischemia (2009) Neurosci. Lett., 461, pp. 266-270
Zhou, M., Xu, W., Liao, G., Bi, X., Baudry, M., Neuroprotection against neonatal hypoxia/ischemia-induced cerebral cell death by prevention of calpain-mediated mGluR1alpha truncation (2009) Exp. Neurol., 218, pp. 75-82
Zipfel, G.J., Lee, J.M., Choi, D.W., Reducing calcium overload in the ischemic brain (1999) N. Engl. J Med., 341, pp. 1543-1544
Albers, G. W., Goldberg, M. P., Choi, D. W., N-methyl-d-aspartate antagonists: Ready for clinical trial in brain ischemia? (1989) Ann. Neurol., 125, pp. 398-40
Armentero, M. T., Fancellu, R., Nappi, G., Bramanti, P., Blandini, F., Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease (2006) Neurobiol. Dis., 22, pp. 1-9
Attucci, S., Carl, V., Mannaioni, G., Moroni, F., Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges (2001) Br. J. Pharmacol., 132, pp. 799-806
Bal zs, R., Miller, S., Romano, C., De Vries, A., Chun, Y., Cotman, C. W., Metabotropic glutamate receptor mGluR5 in astrocytes: Pharmacological properties and agonist regulation (1997) J. Neurochem., 69, pp. 151-163
Black, Y. D., Xiao, D., Pellegrino, D., Kachroo, A., Brownell, A. L., Schwarzschild, M. A., Protective effect of metabotropic glutamate mGluR5 receptor elimination in a 6-hydroxydopamine model of Parkinson's disease (2010) Neurosci. Lett., 486, pp. 161-165
Brakeman, P. R., Lanahan, A. A., O'Brien, R., Roche, K., Barnes, C. A., Huganir, R. L., Worley, P. F., Homer: A protein that selectively binds metabotropic glutamate receptors (1997) Nature, 386, pp. 284-288
Brazil, D. P., Hemmings, B. A., Ten years of protein kinase B signalling: A hard Akt to follow (2001) Trends Biochem. Sci., 26, pp. 657-664
Choi, D. W., Glutamate neurotoxicity and diseases of the nervous system (1988) Neuron, 1, pp. 623-634
Conn, P. J., Battaglia, G., Marino, M. J., Nicoletti, F., Metabotropic glutamate receptors in the basal ganglia motor circuit (2005) Nat. Rev. Neurosci., 6, pp. 787-798
De Vry, J., Horv th, E., Schreiber, R., Neuroprotective and behavioral effects of the selective metabotropic glutamate mGlu (1) receptor antagonist BAY 36-7620 (2001) Eur. J. Pharmacol., 428, pp. 203-214
Doherty, A. J., Palmer, M. J., Henley, J. M., Collingridge, G. L., Jane, D. E., (RS) -2-Chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus (1997) Neuropharmacology, 36, pp. 265-267
Emery, A. C., Pshenichkin, S., Takoudjou, G. R., Grajkowska, E., Wolfe, B. B., Wroblewski, J. T., The Protective Signaling of Metabotropic Glutamate Receptor 1 Is Mediated by Sustained, -Arrestin-1-dependent ERK Phosphorylation (2010) J. Biol. Chem., 285, pp. 26041-26048
Emery A., . C., Hathaway, H., Pshenichkin, S., Takoudjou G., . R., Diraddo, J., Grajkowska, E., Yasuda R., . P., Wroblewski J., . T., Ligand bias at mGlu1 receptors reveals a second binding site at new endogenous agonists (2011) Curr. Neuropharmacol., 9 (S1), p. 18
Engers, D. W., Field, J. R., Le, U., Zhou, Y., Bolinger, J. D., Zamorano, R., Blobaum, A. L., Hopkins, C. R., Discovery, synthesis, and structure-activity relationship development of a series of N- (4-acetamido) phenylpicolinamides as positive allosteric modulators of metabotropic glutamate receptor 4 (mGlu (4)) with CNS exposure in rats (2011) J. Med. Chem., 54, pp. 1106-1110
Gill, S. S., Patel, N. K., Hotton, G. R., O'Sullivan, K., McCarter, R., Bunnage, M., Brooks, D. J., Heywood, P., Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease (2003) Nat. Med., 9, pp. 589-595
Hardingham, G. E., Bading, H., Synaptic versus extra synaptic NMDA receptor signalling: Implications for neurodegenerative disorders (2010) Nat. Rev. Neurosci., 11, pp. 682-696
Jantzie, L. L., Talos, D. M., Selip, D. B., An, L., Jackson, M. C., Folkerth, R. D., Deng, W., Jensen, F. E., Developmental regulation of group i metabotropic glutamate receptors in the premature brain and their protective role in a rodent model of periventricular leukomalacia (2011) Neuron Glia Biol., 14, pp. 1-12
Kinon, B. J., Zhang, L., Millen, B. A., Osuntokun, O. O., Williams, J. E., Kollack-Walker, S., Jackson, K., Jarkova, N., A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia (2011) J. Clin. Psychopharmacol., 31, pp. 349-355. , the HBBI Study Group
Koo, S. J., Pfaff, S. L., Fine-tuning motor neuron properties: Signaling from the periphery (2002) Neuron, 35, pp. 823-826
Lam, A. G., Soriano, M. A., Monn, J. A., Schoepp, D. D., Lodge, D., McCulloch, J., Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemia (1998) Neurosci. Lett., 254, pp. 121-123
Lin, L. F., Doherty, D. H., Lile, J. D., Bektesh, S., Collins, F., GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons (1993) Science, 260, pp. 1130-1132
Lipton, S. A., Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond (2006) Nat. Rev. Drug Discov., 5, pp. 160-170
Loo, D. T., Copani, A., Pike, C. J., Whittemore, E. R., Walencewicz, A. J., Cotman, C. W., Apoptosis is induced by beta-amyloid in cultured central nervous system neurons (1993) Proc. Natl. Acad. Sci. USA, 90, pp. 7951-7955
Marino, M. J., Williams, Jr. D. L., O'Brien, J. A., Valenti, O., McDonald, T. P., Clements, M. K., Wang, R., Conn, P. J., Allosteric modulation of group III metabotropic glutamate receptor 4: A potential approach to Parkinson's disease treatment (2003) Proc. Natl. Acad. Sci. USA, 100, pp. 13668-13673
Masilamoni, G. J., Bogenpohl, J. W., Alagille, D., Delevich, K., Tamagnan, G., Votaw, J. R., Wichmann, T., Smith, Y., Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys (2011) Brain, 134, pp. 2057-2073
Mermelstein, P. G., Membrane-localised oestrogen receptor alpha and beta influence neuronal activity through activation of metabotropic glutamate receptors (2009) J. Neuroendocrinol., 21, pp. 257-262
Micevych, P. E., Mermelstein, P. G., Membrane estrogen receptors acting through metabotropic glutamate receptors: An emerging mechanism of estrogen action in brain (2008) Mol. Neurobiol., 38, pp. 66-77
Moyanova, S. G., Mastroiacovo, F., Kortenska, L. V., Mitreva, R. G., Fardone, E., Santolini, I., Sobrado, M., Ngomba, R. T., Protective role for type 4 metabotropic glutamate receptors against ischemic brain damage (2011) J. Cereb. Blood Flow Metab., 31, pp. 1107-1118
Niswender, C. M., Johnson, K. A., Weaver, C. D., Jones, C. K., Xiang, Z., Luo, Q., Rodriguez, A. L., Conn, P. J., Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4 (2008) Mol. Pharmacol., 74, pp. 1345-1358
Niswender, C. M., Conn, P. J., Metabotropic glutamate receptors: Physiology, pharmacology, and disease (2010) Annu. Rev. Pharmacol. Toxicol., 50, pp. 295-322
Olney, J. W., The toxic effects of glutamate and related compounds in the retina and the brain (1982) Retina, 2, pp. 341-359
Olney, J. W., Wozniak, D. F., Farber, N. B., Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies (1997) Arch. Neurol., 54, pp. 1234-1240
Patil, S. T., Zhang, L., Martenyi, F., Lowe, S. L., Jackson, K. A., Andreev, B. V., Avedisova, A. S., Schoepp, D. D., Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial (2007) Nat. Med., 13, pp. 1102-1107
Price, D. L., Rockenstein, E., Ubhi, K., Phung, V., MacLean-Lewis, N., Askay, D., Cartier, A., Masliah, E., Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy-implications for excitotoxicity (2010) PLoS One, 5, p. 14020
Rong, R., Ahn, J. Y., Huang, H., Nagata, E., Kalman, D., Kapp, J. A., Tu, J., Ye, K., PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis (2003) Nat. Neurosci., 6, pp. 1153-1161
Rothman, S. M., Olney, J. W., Glutamate and the pathophysiology of hypoxic-ischemic brain damage (1986) Ann. Neurol., 19, pp. 105-111
Rothstein, J. D., 1995-1996. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis Clin. Neurosci., 3, pp. 348-359
Schoepp, D. D., Jane, D. E., Monn, J. A., Pharmacological agents acting at subtypes of metabotropic glutamate receptors (1999) Neuropharmacology, 38, pp. 1431-1476
Siesj, B. K., Katsura, K., Kristi n, T., The biochemical basis of cerebral ischemic damage (1995) J. Neurosurg. Anesthesiol., 7, pp. 47-52
Slevin, J. T., Gerhardt, G. A., Smith, C. D., Gash, D. M., Kryscio, R., Young, B., Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor (2005) J. Neurosurg., 102, pp. 216-222
Spampinato, S. F., Molinaro, G., Merlo, S., Iacovelli, L., Caraci, F., Battaglia, G., Nicoletti, F., Sortino, M. A., Estrogen receptors and type-1 metabotropic glutamate receptors are interdependent in protecting cortical Neurons against {beta} -amyloid toxicity (2012) Mol. Pharmacol., 81, pp. 12-20
Taylor, D. L., Diemel, L. T., Pocock, J. M., Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity (2003) J. Neurosci., 23, pp. 2150-2160
Thomas, A. G., Liu, W., Olkowski, J. L., Tang, Z., Lin, Q., Lu, X. C., Slusher, B. S., Neuroprotection mediated by glutamate carboxypeptidase II (NAALADase) inhibition requires TGF-beta (2001) Eur. J. Pharmacol., 430, pp. 33-40
Tu, J. C., Xiao, B., Yuan, J. P., Lanahan, A. A., Leoffert, K., Li, M., Linden, D. J., Worley, P. F., Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors (1998) Neuron, 21, pp. 717-726
Werner, C. G., Scartabelli, T., Pancani, T., Landucci, E., Moroni, F., Pellegrini-Giampietro, D. E., Differential role of mGlu1 and mGlu5 receptors in rat hippocampal slice models of ischemic tolerance (2007) Eur. J. Neurosci., 25, pp. 3597-3604
Xu, W., Wong, T. P., Chery, N., Gaertner, T., Wang, Y. T., Baudry, M., Calpain-mediated mGluR1alpha truncation: A key step in excitotoxicity (2007) Neuron, 53, pp. 399-412
Zipfel, G. J., Lee, J. M., Choi, D. W., Reducing calcium overload in the ischemic brain (1999) N. Engl. J Med., 341, pp. 1543-1544
Metabotropic glutamate receptors in neurodegeneration/neuroprotection: Still a hot topic?
Moving from early studies, we here review the most recent evidence linking metabotropic glutamate (mGlu) receptors to processes of neurodegeneration/ neuroprotection. The use of knockout mice and subtype-selective drugs has increased our knowledge of the precise role played by individual mGlu receptor subtypes in these processes. Activation of mGlu1 and mGlu5 receptors may either amplify or reduce neuronal damage depending on the context and the nature of the toxic insults. In contrast, mGlu1 and mGlu5 receptors antagonists are consistently protective in in vitro and in vivo models of neuronal death. A series of studies suggest that mGlu1 receptor antagonists or negative allosteric modulators (NAMs) are promising candidates for the treatment of ischemic brain damage, whereas mGlu5 receptor NAMs, which have been clinically developed for the treatment of Parkinson's disease (PD) and l-DOPA-induced dyskinesias, protect nigro-striatal dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) toxicity in mice and monkeys. Activation of glial mGlu3 receptors promotes the formation of various neurotrophic factors, such as transforming growth factor-β (TGF-β), glial-derived neurotrophic factor (GDNF), nerve growth factor (NGF), and brain-derived neurotrophic factor (BDNF). Hence, selective mGlu3 receptor agonists or positive allosteric modulators (PAMs) (not yet available) are potentially helpful in the treatment of chronic neurodegenerative disorders such as PD, Alzheimer's disease (AD), and amyotrophic lateral sclerosis. Selective mGlu2 receptor PAMs should be used with caution in AD patients because these drugs are shown to amplify β-amyloid neurotoxicity. Finally, mGlu4 receptor agonists/PAMs share with mGlu5 receptor NAMs the ability to improve motor symptoms associated with PD and attenuate nigro-striatal degeneration at the same time. No data are yet available on the role of mGlu7 and mGlu8 receptors in neurodegeneration/ neuroprotection. © 2012 Elsevier Ltd. All rights reserved.
Moving from early studies, we here review the most recent evidence linking metabotropic glutamate (mGlu) receptors to processes of neurodegeneration/ neuroprotection. The use of knockout mice and subtype-selective drugs has increased our knowledge of the precise role played by individual mGlu receptor subtypes in these processes. Activation of mGlu1 and mGlu5 receptors may either amplify or reduce neuronal damage depending on the context and the nature of the toxic insults. In contrast, mGlu1 and mGlu5 receptors antagonists are consistently protective in in vitro and in vivo models of neuronal death. A series of studies suggest that mGlu1 receptor antagonists or negative allosteric modulators (NAMs) are promising candidates for the treatment of ischemic brain damage, whereas mGlu5 receptor NAMs, which have been clinically developed for the treatment of Parkinson's disease (PD) and l-DOPA-induced dyskinesias, protect nigro-striatal dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) toxicity in mice and monkeys. Activation of glial mGlu3 receptors promotes the formation of various neurotrophic factors, such as transforming growth factor-β (TGF-β), glial-derived neurotrophic factor (GDNF), nerve growth factor (NGF), and brain-derived neurotrophic factor (BDNF). Hence, selective mGlu3 receptor agonists or positive allosteric modulators (PAMs) (not yet available) are potentially helpful in the treatment of chronic neurodegenerative disorders such as PD, Alzheimer's disease (AD), and amyotrophic lateral sclerosis. Selective mGlu2 receptor PAMs should be used with caution in AD patients because these drugs are shown to amplify β-amyloid neurotoxicity. Finally, mGlu4 receptor agonists/PAMs share with mGlu5 receptor NAMs the ability to improve motor symptoms associated with PD and attenuate nigro-striatal degeneration at the same time. No data are yet available on the role of mGlu7 and mGlu8 receptors in neurodegeneration/ neuroprotection. © 2012 Elsevier Ltd. All rights reserved.
Metabotropic glutamate receptors in neurodegeneration/neuroprotection: Still a hot topic?
No results. |
Metabotropic glutamate receptors in neurodegeneration/neuroprotection: Still a hot topic?
Other filter: ([btitle,keywords] "Brain Ischemia" OR [ ...
Pepe G, Calce E, Verdoliva V, Saviano M, Maglione V, Di Pardo A, De Luca S
* Curcumin-Loaded Nanoparticles Based on Amphiphilic Hyaluronan-Conjugate Explored as Targeting Delivery System for Neurodegenerative Disorders (60 views)
Int J Mol Sc (ISSN: 1422-0067linking, 1422-0067electronic, 1661-6596), 2020 Nov 23; 21(22): N/D-N/D.
Impact Factor: 4.556
View Export to BibTeX Export to EndNote
Nicoletti F, Orlando R, Di Menna L, Cannella M, Notartomaso S, Mascio G, Iacovelli L, Matrisciano F, Fazio F, Caraci F, Copani A, Battaglia G, Bruno V
* Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in Schizophrenia (149 views)
Front Psychiatry (ISSN: 1664-0640linking, 1664-0640electronic), 2019 Feb 14; 10: 49-49.
Impact Factor: 2.857
View Export to BibTeX Export to EndNote
Spampinato SF, Copani A, Nicoletti F, Sortino MA, Caraci F
* Metabotropic Glutamate Receptors in Glial Cells: A New Potential Target for Neuroprotection? (412 views)
Front Mol Neurosci (ISSN: 1662-5099, 1662-5099linking, 1662-5099electronic), 2018 Nov 13; 11: 414-414.
Impact Factor: 3.902
View Export to BibTeX Export to EndNote
Supuran CT, Alterio V, Di Fiore A, D'Ambrosio K, Carta F, Monti SM, De Simone G
* Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one (567 views)
Med Res Rev (ISSN: 1098-1128electronic, 0198-6325linking), 2018 Sep; 38(6): 1799-1836.
Impact Factor: 8.29
View Export to BibTeX Export to EndNote
Lanza V, Milardi D, Di Natale G, Pappalardo G
* Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases (853 views)
Curr Med Chem (ISSN: 1875-533xelectronic, 0929-8673linking), 2018 Feb 12; 25(4): 525-539.
Impact Factor: 3.249
View Export to BibTeX Export to EndNote
Di Menna L, Joffe ME, Iacovelli L, Orlando R, Lindsley CW, Mairesse J, Gressèns P, Cannella M, Caraci F, Copani A, Bruno V, Battaglia G, Conn PJ, Nicoletti F
* Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system (399 views)
Neuropharm (ISSN: 0028-3908linking, 1873-7064electronic), 2018 Jan; 128: 301-313.
Impact Factor: 3.383
View Export to BibTeX Export to EndNote
Caraci F, Nicoletti F, Copani A
* Metabotropic glutamate receptors: the potential for therapeutic applications in Alzheimer's disease (544 views)
Curr Opin Pharmacol (ISSN: 1471-4892), 2017 Dec 23; 38: 1-7.
Impact Factor: 6.313
View Export to BibTeX Export to EndNote
Sciacca MFM, Romanucci V, Zarrelli A, Monaco I, Lolicato F, Spinella N, Galati C, Grasso G, D'Urso L, Romeo M, Diomede L, Salmona M, Bongiorno C, Di Fabio G, La Rosa C, Milardi D
* Inhibition of Abeta Amyloid Growth and Toxicity by Silybins: The Crucial Role of Stereochemistry (401 views) (PDF 194 views)
Acs Chem Neurosci (ISSN: 1948-7193, 1948-7193electronic), 2017 Jun 09; N/D: N/D-N/D.
Impact Factor: 4.211
View Export to BibTeX Export to EndNote
Copani A
* The underexplored question of beta-amyloid monomers (299 views)
Eur J Pharmacol (ISSN: 0014-2999), 2017 May 31; N/D: N/D-N/D.
Impact Factor: 3.04
View Export to BibTeX Export to EndNote
Caraci F, Bruno V, Copani A, Matrisciano F, Nicoletti F, Battaglia G
* The impact of metabotropic glutamate receptors into active neurodegenerative processes: A "dark side" in the development of new symptomatic treatments for neurologic and psychiatric disorders (291 views)
Neuropharm (ISSN: 0028-3908, 1873-7064electronic, 0028-3908linking), 2017 Mar 15; 115: 180-192.
Impact Factor: 5.012
View Export to BibTeX Export to EndNote
D'Andrea LD, Rosa LD, Vigliotti C, Cataldi M
* VEGF mimic peptides: Potential applications in central nervous system therapeutics (781 views)
New Horizons Transl Med (ISSN: 2307-5023), 2017; 3(5): 233-251.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Caraci F, Tascedda F, Merlo F, Benatti C, Spampinato S, Munafò A, Leggio GM, Nicoletti F, Brunello N, Drago F, Sortino MA, Copani A
* Fluoxetine Prevents Ab1-42-Induced Toxicity via a Paracrine Signaling Mediated by Transforming-Growth- Factor-b1 (291 views) (PDF 202 views)
Frontiers In Pharmacology, 2016 Oct; 7: 1-11.
Impact Factor: 4.418
View Export to BibTeX Export to EndNote
Pignataro G, Ziaco B, Tortiglione A, Gala R, Cuomo O, Vinciguerra A, Lapi D, Mastantuono T, Anzilotti S, D'Andrea LD, Pedone C, Di Renzo G, Annunziato L, Cataldi M
* Neuroprotective Effect of VEGF-Mimetic Peptide QK in Experimental Brain Ischemia Induced in Rat by Middle Cerebral Artery Occlusion (286 views)
Acs Chem Neurosci (ISSN: 1948-7193, 1948-7193electronic), 2015 Sep 16; 6(9): 1517-1525.
Impact Factor: 4.348
View Export to BibTeX Export to EndNote
Caraci F, Pappalardo G, Basile L, Giuffrida A, Copani A, Tosto R, Sinopoli A, Giuffrida ML, Pirrone E, Drago F, Pignatello R, Guccione S
* Neuroprotective effects of the monoamine oxidase inhibitor Tranylcypromine and its amide derivatives against Abeta(1-42)-induced toxicity (806 views)
Eur J Pharmacol (ISSN: 0014-2999), 2015 Jul 7; 764: 256-263.
Impact Factor: 2.73
View Export to BibTeX Export to EndNote
Travaglia A, Pietropaolo A, Di Martino R, Nicoletti VG, La Mendola D, Calissano P, Rizzarelli E
* A Small Linear Peptide Encompassing the NGF N-Terminus Partly Mimics the Biological Activities of the Entire Neurotrophin in PC12 Cells (338 views)
Acs Chem Neurosci (ISSN: 1948-7193, 1948-7193electronic, 1948-7193linking), 2015; 6(8): 1379-1392.
Impact Factor: 4.348
View Export to BibTeX Export to EndNote
Doti N, Reuther C, Scognamiglio PL, Dolga AM, Plesnila N, Ruvo M, Culmsee C
* Inhibition of the AIF/CypA complex protects against intrinsic death pathways induced by oxidative stress (565 views)
Cell Death & (ISSN: 2041-4889, 2041-4889electronic), 2014 Jan 16; 5(1): e993-e993.
Impact Factor: 5.014
View Export to BibTeX Export to EndNote
Travaglia A, La Mendola D, Magrì A, Nicoletti VG, Pietropaolo A, Rizzarelli E
* Copper, BDNF and Its N-terminal domain: inorganic features and biological perspectives (522 views)
Chemistry (ISSN: 1521-3765, 0947-6539, 1521-3765electronic), 2012 Dec 3; 18(49): 15618-15631.
Impact Factor: 5.831
View Export to BibTeX Export to EndNote
Calabrese V, Cornelius C, Dinkova-Kostova AT, Iavicoli I, Di Paola R, Koverech A, Cuzzocrea S, Rizzarelli E, Calabrese EJ
* Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity (4500 views)
Bba-Gen Subjects (ISSN: 0006-3002, 0925-4439, 1570-9639), 2012 May; 1822(5): 753-783.
Impact Factor: 3.733
View Export to BibTeX Export to EndNote
Cirillo G, Colangelo AM, Bianco MR, Cavaliere C, Zaccaro L, Sarmientos P, Alberghina L, Papa M
* BB14, a Nerve Growth Factor (NGF)-like peptide shown to be effective in reducing reactive astrogliosis and restoring synaptic homeostasis in a rat model of peripheral nerve injury (402 views)
Biotechnology Advances (ISSN: 0734-9750), 2012 Jan; 30(1): 223-232.
Impact Factor: 9.599
View Export to BibTeX Export to EndNote
Caraci F, Spampinato S, Sortino MA, Bosco P, Battaglia G, Bruno V, Drago F, Nicoletti F, Copani A
* Dysfunction of TGF-β1 signaling in Alzheimer's disease: Perspectives for neuroprotection (1289 views)
Cell Tissue Res (ISSN: 0302-766x), 2012 Jan; 347(1): 291-301.
Impact Factor: 3.677
View Export to BibTeX Export to EndNote
Santulli G, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S, Maione AS, Condorelli G, Puca A, Trimarco B, Illario M, Iaccarino G
* CaMK4 gene deletion induces hypertension (349 views)
J Am Heart Assoc Journal Of The American Heart Association (ISSN: 2047-9980), 2012; 1(4): N/D-N/D.
Impact Factor: 2.882
View Export to BibTeX Export to EndNote
Calabrese V, Cornelius C, Cuzzocrea S, Iavicoli I, Rizzarelli E, Calabrese EJ
* Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity (900 views)
Molecular Aspects Of Medicine (ISSN: 1872-9452, 0098-2997), 2011 Sep; 32(4-6): 279-304.
Impact Factor: 9.97
View Export to BibTeX Export to EndNote
Bellia F, Vecchio G, Cuzzocrea S, Calabrese V, Rizzarelli E
* Neuroprotective features of carnosine in oxidative driven diseases (491 views)
Molecular Aspects Of Medicine (ISSN: 1872-9452, 0098-2997), 2011 Sep; 32(4-6): 258-266.
Impact Factor: 9.97
View Export to BibTeX Export to EndNote
Cirillo G, Bianco MR, Colangelo AM, Cavaliere C, Daniele DL, Zaccaro L, Alberghina L, Papa M
* Reactive astrocytosis-induced perturbation of synaptic homeostasis is restored by nerve growth factor (460 views)
Neurobiology Of Disease (ISSN: 0969-9961), 2011 Mar; 41(3): 630-639.
Impact Factor: 5.403
View Export to BibTeX Export to EndNote
Caraci F, Molinaro G, Battaglia G, Giuffrida ML, Riozzi B, Traficante A, Bruno V, Cannella M, Merlo S, Wang X, Heinz BA, Nisenbaum ES, Britton TC, Drago F, Sortino MA, Copani A, Nicoletti F
* Targeting group II Metabotropic Glutamate (mGlu) receptors for the treatment of psychosis associated with alzheimer's disease: Selective activation of mGlu2 receptors amplifies β-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective (765 views)
Mol Pharmacol (ISSN: 0026-895x), 2011 Mar; 79(3): 618-626.
Impact Factor: 4.883
View Export to BibTeX Export to EndNote
Spina-Purrello V, Giliberto S, Barresi V, Nicoletti VG, Giuffrida Stella AM, Rizzarelli E
* Modulation of PARP-1 and PARP-2 expression by L-carnosine and trehalose after LPS and INFγ-induced oxidative stress (450 views)
Neurochemical Research (ISSN: 0364-3190, 1573-6903), 2010 Dec; 35(12): 2144-2153.
Impact Factor: 2.608
View Export to BibTeX Export to EndNote
Giuffrida ML, Caraci F, De Bona P, Pappalardo G, Nicoletti F, Rizzarelli E, Copani A
* The monomer state of beta-amyloid: where the Alzheimer's disease protein meets physiology (681 views)
Rev Neurosci (ISSN: 0334-1763), 2010; 21(2): 83-93.
Impact Factor: 2.047
View Export to BibTeX Export to EndNote
Kapucu OL, Nobili F, Varrone A, Booij J, Vander Borght T, Nagren K, Darcourt J, Tatsch K, Van Laere KJ
* EANM procedure guideline for brain perfusion SPECT using Tc-99m-labelled radiopharmaceuticals, version (580 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Dec; 36(12): 2093-2102.
Impact Factor: 4.531
View Export to BibTeX Export to EndNote
Calabrese V, Cornelius C, Rizzarelli E, Owen JB, Dinkova-Kostova AT, Butterfield DA
* Nitric oxide in cell survival: a janus molecule (1106 views)
Antioxid Redox Signal (ISSN: 1557-7716, 1523-0864, 1523-0864linking), 2009 Nov; 11(11): 2717-2739.
Impact Factor: 7.581
View Export to BibTeX Export to EndNote
Calabrese V, Cornelius C, Mancuso C, Barone E, Calafato S, Bates T, Rizzarelli E, Kostova AT
* Vitagenes, dietary antioxidants and neuroprotection in neurodegenerative diseases (1481 views)
Frontiers In Bioscience (ISSN: 1093-4715, 1093-9946), 2009 Jan 1; 14: 376-397.
Impact Factor: 3.736
View Export to BibTeX Export to EndNote
Calabrese V, Cornelius C, Mancuso C, Pennisi G, Calafato S, Bellia F, Bates TE, Giuffrida Stella AM, Schapira T, Dinkova Kostova AT, Rizzarelli E
* Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity (1402 views)
Neurochemical Research (ISSN: 1573-6903, 0364-3190), 2008 Dec; 33(12): 2444-2471.
Impact Factor: 2.26
View Export to BibTeX Export to EndNote
Castiglione M, Calafiore M, Costa L, Sortino MA, Nicoletti F, Copani A
* Group I metabotropic glutamate receptors control proliferation, survival and differentiation of cultured neural progenitor cells isolated from the subventricular zone of adult mice (490 views)
Neuropharm (ISSN: 0028-3908, 1873-7064electronic, 0028-3908linking), 2008 Sep; 55(4): 560-567.
Impact Factor: 3.383
View Export to BibTeX Export to EndNote
Gustavsson T, Banyasz A, Sarkar N, Markovitsi D, Improta R
* Statin: New life for an old drug (365 views)
Pharmacol Res Academic Press, 2008 Jun 23; 350(1-3): 1-2.
Impact Factor: 3.976
View Export to BibTeX Export to EndNote
Caraci F, Battaglia G, Busceti C, Biagioni F, Mastroiacovo F, Bosco P, Drago F, Nicoletti F, Sortino MA, Copani A
* TGF-β1 protects against Aβ-neurotoxicity via the phosphatidylinositol-3-kinase pathway (440 views)
Neurobiology Of Disease (ISSN: 0969-9961), 2008 May; 30(2): 234-242.
Impact Factor: 4.852
View Export to BibTeX Export to EndNote
Copani A, Guccione S, Giurato L, Caraci F, Calafiore M, Sortino MA
* The cell cycle molecules behind neurodegeneration in Alzheimer's disease: Perspectives for drug development (454 views)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2008; 15(24): 2420-2432.
Impact Factor: 4.823
View Export to BibTeX Export to EndNote
Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM
* Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity (1004 views)
Nature Reviews Neuroscience (ISSN: 1471-0048), 2007 Oct; 8(10): 766-775.
Impact Factor: 24.52
View Export to BibTeX Export to EndNote
Nicoletti VG, Santoro AM, Grasso G, Vagliasindi LI, Giuffrida ML, Cuppari C, Purrello VS, Stella AMG, Rizzarelli E
* Carnosine interaction with nitric oxide and astroglial cell protection (668 views)
Journal Of Neuroscience Research (ISSN: 0360-4012), 2007 Sep 1; 85(10): 2239-2245.
Impact Factor: 3.268
View Export to BibTeX Export to EndNote
Pappata S
* Tracking the dynamics of secondary degeneration after stroke (329 views)
J Neurol Neurosurg Psychiatry (ISSN: 0022-3050), 2007 Jun; 78(6): 554-554.
Impact Factor: 3.857
View Export to BibTeX Export to EndNote
Marrazzo A, Caraci F, Salinaro ET, Su TP, Copani A, Ronsisvalle G
* Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity (585 views)
Neuroreport (ISSN: 0959-4965), 2005 Sep 1; 16(11): 1223-1226.
Impact Factor: 1.995
View Export to BibTeX Export to EndNote
Calabrese V, Colombrita C, Guagliano E, Sapienza M, Ravagna A, Cardile V, Scapagnini G, Santoro AM, Mangiameli A, Butterfield DA, Giuffrida Stella AM, Rizzarelli E
* Protective effect of carnosine during nitrosative stress in astroglial cell cultures (448 views)
Neurochemical Research (ISSN: 0364-3190, 1573-6903), 2005 Jun; 30(6-7): 797-807.
Impact Factor: 2.187
View Export to BibTeX Export to EndNote
Filippo C, Mariangela C, Giuseppina F, Pier Luigi C, Angelo B, Marco C, Giuseppe B, Paolo B, Ferdinando N, Agata C, Maria Angela S
* Nicergoline, a drug used for age-dependent cognitive impairment, protects cultured neurons against β-amyloid toxicity (808 views)
Brain Res (ISSN: 0006-8993), 2005; 1047(1): 30-37.
Impact Factor: 2.296
View Export to BibTeX Export to EndNote
* Curcumin-Loaded Nanoparticles Based on Amphiphilic Hyaluronan-Conjugate Explored as Targeting Delivery System for Neurodegenerative Disorders (60 views)
Int J Mol Sc (ISSN: 1422-0067linking, 1422-0067electronic, 1661-6596), 2020 Nov 23; 21(22): N/D-N/D.
Impact Factor: 4.556
View Export to BibTeX Export to EndNote
Nicoletti F, Orlando R, Di Menna L, Cannella M, Notartomaso S, Mascio G, Iacovelli L, Matrisciano F, Fazio F, Caraci F, Copani A, Battaglia G, Bruno V
* Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in Schizophrenia (149 views)
Front Psychiatry (ISSN: 1664-0640linking, 1664-0640electronic), 2019 Feb 14; 10: 49-49.
Impact Factor: 2.857
View Export to BibTeX Export to EndNote
Spampinato SF, Copani A, Nicoletti F, Sortino MA, Caraci F
* Metabotropic Glutamate Receptors in Glial Cells: A New Potential Target for Neuroprotection? (412 views)
Front Mol Neurosci (ISSN: 1662-5099, 1662-5099linking, 1662-5099electronic), 2018 Nov 13; 11: 414-414.
Impact Factor: 3.902
View Export to BibTeX Export to EndNote
Supuran CT, Alterio V, Di Fiore A, D'Ambrosio K, Carta F, Monti SM, De Simone G
* Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one (567 views)
Med Res Rev (ISSN: 1098-1128electronic, 0198-6325linking), 2018 Sep; 38(6): 1799-1836.
Impact Factor: 8.29
View Export to BibTeX Export to EndNote
Lanza V, Milardi D, Di Natale G, Pappalardo G
* Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases (853 views)
Curr Med Chem (ISSN: 1875-533xelectronic, 0929-8673linking), 2018 Feb 12; 25(4): 525-539.
Impact Factor: 3.249
View Export to BibTeX Export to EndNote
Di Menna L, Joffe ME, Iacovelli L, Orlando R, Lindsley CW, Mairesse J, Gressèns P, Cannella M, Caraci F, Copani A, Bruno V, Battaglia G, Conn PJ, Nicoletti F
* Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system (399 views)
Neuropharm (ISSN: 0028-3908linking, 1873-7064electronic), 2018 Jan; 128: 301-313.
Impact Factor: 3.383
View Export to BibTeX Export to EndNote
Caraci F, Nicoletti F, Copani A
* Metabotropic glutamate receptors: the potential for therapeutic applications in Alzheimer's disease (544 views)
Curr Opin Pharmacol (ISSN: 1471-4892), 2017 Dec 23; 38: 1-7.
Impact Factor: 6.313
View Export to BibTeX Export to EndNote
Sciacca MFM, Romanucci V, Zarrelli A, Monaco I, Lolicato F, Spinella N, Galati C, Grasso G, D'Urso L, Romeo M, Diomede L, Salmona M, Bongiorno C, Di Fabio G, La Rosa C, Milardi D
* Inhibition of Abeta Amyloid Growth and Toxicity by Silybins: The Crucial Role of Stereochemistry (401 views) (PDF 194 views)
Acs Chem Neurosci (ISSN: 1948-7193, 1948-7193electronic), 2017 Jun 09; N/D: N/D-N/D.
Impact Factor: 4.211
View Export to BibTeX Export to EndNote
Copani A
* The underexplored question of beta-amyloid monomers (299 views)
Eur J Pharmacol (ISSN: 0014-2999), 2017 May 31; N/D: N/D-N/D.
Impact Factor: 3.04
View Export to BibTeX Export to EndNote
Caraci F, Bruno V, Copani A, Matrisciano F, Nicoletti F, Battaglia G
* The impact of metabotropic glutamate receptors into active neurodegenerative processes: A "dark side" in the development of new symptomatic treatments for neurologic and psychiatric disorders (291 views)
Neuropharm (ISSN: 0028-3908, 1873-7064electronic, 0028-3908linking), 2017 Mar 15; 115: 180-192.
Impact Factor: 5.012
View Export to BibTeX Export to EndNote
D'Andrea LD, Rosa LD, Vigliotti C, Cataldi M
* VEGF mimic peptides: Potential applications in central nervous system therapeutics (781 views)
New Horizons Transl Med (ISSN: 2307-5023), 2017; 3(5): 233-251.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Caraci F, Tascedda F, Merlo F, Benatti C, Spampinato S, Munafò A, Leggio GM, Nicoletti F, Brunello N, Drago F, Sortino MA, Copani A
* Fluoxetine Prevents Ab1-42-Induced Toxicity via a Paracrine Signaling Mediated by Transforming-Growth- Factor-b1 (291 views) (PDF 202 views)
Frontiers In Pharmacology, 2016 Oct; 7: 1-11.
Impact Factor: 4.418
View Export to BibTeX Export to EndNote
Pignataro G, Ziaco B, Tortiglione A, Gala R, Cuomo O, Vinciguerra A, Lapi D, Mastantuono T, Anzilotti S, D'Andrea LD, Pedone C, Di Renzo G, Annunziato L, Cataldi M
* Neuroprotective Effect of VEGF-Mimetic Peptide QK in Experimental Brain Ischemia Induced in Rat by Middle Cerebral Artery Occlusion (286 views)
Acs Chem Neurosci (ISSN: 1948-7193, 1948-7193electronic), 2015 Sep 16; 6(9): 1517-1525.
Impact Factor: 4.348
View Export to BibTeX Export to EndNote
Caraci F, Pappalardo G, Basile L, Giuffrida A, Copani A, Tosto R, Sinopoli A, Giuffrida ML, Pirrone E, Drago F, Pignatello R, Guccione S
* Neuroprotective effects of the monoamine oxidase inhibitor Tranylcypromine and its amide derivatives against Abeta(1-42)-induced toxicity (806 views)
Eur J Pharmacol (ISSN: 0014-2999), 2015 Jul 7; 764: 256-263.
Impact Factor: 2.73
View Export to BibTeX Export to EndNote
Travaglia A, Pietropaolo A, Di Martino R, Nicoletti VG, La Mendola D, Calissano P, Rizzarelli E
* A Small Linear Peptide Encompassing the NGF N-Terminus Partly Mimics the Biological Activities of the Entire Neurotrophin in PC12 Cells (338 views)
Acs Chem Neurosci (ISSN: 1948-7193, 1948-7193electronic, 1948-7193linking), 2015; 6(8): 1379-1392.
Impact Factor: 4.348
View Export to BibTeX Export to EndNote
Doti N, Reuther C, Scognamiglio PL, Dolga AM, Plesnila N, Ruvo M, Culmsee C
* Inhibition of the AIF/CypA complex protects against intrinsic death pathways induced by oxidative stress (565 views)
Cell Death & (ISSN: 2041-4889, 2041-4889electronic), 2014 Jan 16; 5(1): e993-e993.
Impact Factor: 5.014
View Export to BibTeX Export to EndNote
Travaglia A, La Mendola D, Magrì A, Nicoletti VG, Pietropaolo A, Rizzarelli E
* Copper, BDNF and Its N-terminal domain: inorganic features and biological perspectives (522 views)
Chemistry (ISSN: 1521-3765, 0947-6539, 1521-3765electronic), 2012 Dec 3; 18(49): 15618-15631.
Impact Factor: 5.831
View Export to BibTeX Export to EndNote
Calabrese V, Cornelius C, Dinkova-Kostova AT, Iavicoli I, Di Paola R, Koverech A, Cuzzocrea S, Rizzarelli E, Calabrese EJ
* Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity (4500 views)
Bba-Gen Subjects (ISSN: 0006-3002, 0925-4439, 1570-9639), 2012 May; 1822(5): 753-783.
Impact Factor: 3.733
View Export to BibTeX Export to EndNote
Cirillo G, Colangelo AM, Bianco MR, Cavaliere C, Zaccaro L, Sarmientos P, Alberghina L, Papa M
* BB14, a Nerve Growth Factor (NGF)-like peptide shown to be effective in reducing reactive astrogliosis and restoring synaptic homeostasis in a rat model of peripheral nerve injury (402 views)
Biotechnology Advances (ISSN: 0734-9750), 2012 Jan; 30(1): 223-232.
Impact Factor: 9.599
View Export to BibTeX Export to EndNote
Caraci F, Spampinato S, Sortino MA, Bosco P, Battaglia G, Bruno V, Drago F, Nicoletti F, Copani A
* Dysfunction of TGF-β1 signaling in Alzheimer's disease: Perspectives for neuroprotection (1289 views)
Cell Tissue Res (ISSN: 0302-766x), 2012 Jan; 347(1): 291-301.
Impact Factor: 3.677
View Export to BibTeX Export to EndNote
Santulli G, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S, Maione AS, Condorelli G, Puca A, Trimarco B, Illario M, Iaccarino G
* CaMK4 gene deletion induces hypertension (349 views)
J Am Heart Assoc Journal Of The American Heart Association (ISSN: 2047-9980), 2012; 1(4): N/D-N/D.
Impact Factor: 2.882
View Export to BibTeX Export to EndNote
Calabrese V, Cornelius C, Cuzzocrea S, Iavicoli I, Rizzarelli E, Calabrese EJ
* Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity (900 views)
Molecular Aspects Of Medicine (ISSN: 1872-9452, 0098-2997), 2011 Sep; 32(4-6): 279-304.
Impact Factor: 9.97
View Export to BibTeX Export to EndNote
Bellia F, Vecchio G, Cuzzocrea S, Calabrese V, Rizzarelli E
* Neuroprotective features of carnosine in oxidative driven diseases (491 views)
Molecular Aspects Of Medicine (ISSN: 1872-9452, 0098-2997), 2011 Sep; 32(4-6): 258-266.
Impact Factor: 9.97
View Export to BibTeX Export to EndNote
Cirillo G, Bianco MR, Colangelo AM, Cavaliere C, Daniele DL, Zaccaro L, Alberghina L, Papa M
* Reactive astrocytosis-induced perturbation of synaptic homeostasis is restored by nerve growth factor (460 views)
Neurobiology Of Disease (ISSN: 0969-9961), 2011 Mar; 41(3): 630-639.
Impact Factor: 5.403
View Export to BibTeX Export to EndNote
Caraci F, Molinaro G, Battaglia G, Giuffrida ML, Riozzi B, Traficante A, Bruno V, Cannella M, Merlo S, Wang X, Heinz BA, Nisenbaum ES, Britton TC, Drago F, Sortino MA, Copani A, Nicoletti F
* Targeting group II Metabotropic Glutamate (mGlu) receptors for the treatment of psychosis associated with alzheimer's disease: Selective activation of mGlu2 receptors amplifies β-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective (765 views)
Mol Pharmacol (ISSN: 0026-895x), 2011 Mar; 79(3): 618-626.
Impact Factor: 4.883
View Export to BibTeX Export to EndNote
Spina-Purrello V, Giliberto S, Barresi V, Nicoletti VG, Giuffrida Stella AM, Rizzarelli E
* Modulation of PARP-1 and PARP-2 expression by L-carnosine and trehalose after LPS and INFγ-induced oxidative stress (450 views)
Neurochemical Research (ISSN: 0364-3190, 1573-6903), 2010 Dec; 35(12): 2144-2153.
Impact Factor: 2.608
View Export to BibTeX Export to EndNote
Giuffrida ML, Caraci F, De Bona P, Pappalardo G, Nicoletti F, Rizzarelli E, Copani A
* The monomer state of beta-amyloid: where the Alzheimer's disease protein meets physiology (681 views)
Rev Neurosci (ISSN: 0334-1763), 2010; 21(2): 83-93.
Impact Factor: 2.047
View Export to BibTeX Export to EndNote
Kapucu OL, Nobili F, Varrone A, Booij J, Vander Borght T, Nagren K, Darcourt J, Tatsch K, Van Laere KJ
* EANM procedure guideline for brain perfusion SPECT using Tc-99m-labelled radiopharmaceuticals, version (580 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Dec; 36(12): 2093-2102.
Impact Factor: 4.531
View Export to BibTeX Export to EndNote
Calabrese V, Cornelius C, Rizzarelli E, Owen JB, Dinkova-Kostova AT, Butterfield DA
* Nitric oxide in cell survival: a janus molecule (1106 views)
Antioxid Redox Signal (ISSN: 1557-7716, 1523-0864, 1523-0864linking), 2009 Nov; 11(11): 2717-2739.
Impact Factor: 7.581
View Export to BibTeX Export to EndNote
Calabrese V, Cornelius C, Mancuso C, Barone E, Calafato S, Bates T, Rizzarelli E, Kostova AT
* Vitagenes, dietary antioxidants and neuroprotection in neurodegenerative diseases (1481 views)
Frontiers In Bioscience (ISSN: 1093-4715, 1093-9946), 2009 Jan 1; 14: 376-397.
Impact Factor: 3.736
View Export to BibTeX Export to EndNote
Calabrese V, Cornelius C, Mancuso C, Pennisi G, Calafato S, Bellia F, Bates TE, Giuffrida Stella AM, Schapira T, Dinkova Kostova AT, Rizzarelli E
* Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity (1402 views)
Neurochemical Research (ISSN: 1573-6903, 0364-3190), 2008 Dec; 33(12): 2444-2471.
Impact Factor: 2.26
View Export to BibTeX Export to EndNote
Castiglione M, Calafiore M, Costa L, Sortino MA, Nicoletti F, Copani A
* Group I metabotropic glutamate receptors control proliferation, survival and differentiation of cultured neural progenitor cells isolated from the subventricular zone of adult mice (490 views)
Neuropharm (ISSN: 0028-3908, 1873-7064electronic, 0028-3908linking), 2008 Sep; 55(4): 560-567.
Impact Factor: 3.383
View Export to BibTeX Export to EndNote
Gustavsson T, Banyasz A, Sarkar N, Markovitsi D, Improta R
* Statin: New life for an old drug (365 views)
Pharmacol Res Academic Press, 2008 Jun 23; 350(1-3): 1-2.
Impact Factor: 3.976
View Export to BibTeX Export to EndNote
Caraci F, Battaglia G, Busceti C, Biagioni F, Mastroiacovo F, Bosco P, Drago F, Nicoletti F, Sortino MA, Copani A
* TGF-β1 protects against Aβ-neurotoxicity via the phosphatidylinositol-3-kinase pathway (440 views)
Neurobiology Of Disease (ISSN: 0969-9961), 2008 May; 30(2): 234-242.
Impact Factor: 4.852
View Export to BibTeX Export to EndNote
Copani A, Guccione S, Giurato L, Caraci F, Calafiore M, Sortino MA
* The cell cycle molecules behind neurodegeneration in Alzheimer's disease: Perspectives for drug development (454 views)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2008; 15(24): 2420-2432.
Impact Factor: 4.823
View Export to BibTeX Export to EndNote
Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM
* Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity (1004 views)
Nature Reviews Neuroscience (ISSN: 1471-0048), 2007 Oct; 8(10): 766-775.
Impact Factor: 24.52
View Export to BibTeX Export to EndNote
Nicoletti VG, Santoro AM, Grasso G, Vagliasindi LI, Giuffrida ML, Cuppari C, Purrello VS, Stella AMG, Rizzarelli E
* Carnosine interaction with nitric oxide and astroglial cell protection (668 views)
Journal Of Neuroscience Research (ISSN: 0360-4012), 2007 Sep 1; 85(10): 2239-2245.
Impact Factor: 3.268
View Export to BibTeX Export to EndNote
Pappata S
* Tracking the dynamics of secondary degeneration after stroke (329 views)
J Neurol Neurosurg Psychiatry (ISSN: 0022-3050), 2007 Jun; 78(6): 554-554.
Impact Factor: 3.857
View Export to BibTeX Export to EndNote
Marrazzo A, Caraci F, Salinaro ET, Su TP, Copani A, Ronsisvalle G
* Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity (585 views)
Neuroreport (ISSN: 0959-4965), 2005 Sep 1; 16(11): 1223-1226.
Impact Factor: 1.995
View Export to BibTeX Export to EndNote
Calabrese V, Colombrita C, Guagliano E, Sapienza M, Ravagna A, Cardile V, Scapagnini G, Santoro AM, Mangiameli A, Butterfield DA, Giuffrida Stella AM, Rizzarelli E
* Protective effect of carnosine during nitrosative stress in astroglial cell cultures (448 views)
Neurochemical Research (ISSN: 0364-3190, 1573-6903), 2005 Jun; 30(6-7): 797-807.
Impact Factor: 2.187
View Export to BibTeX Export to EndNote
Filippo C, Mariangela C, Giuseppina F, Pier Luigi C, Angelo B, Marco C, Giuseppe B, Paolo B, Ferdinando N, Agata C, Maria Angela S
* Nicergoline, a drug used for age-dependent cognitive impairment, protects cultured neurons against β-amyloid toxicity (808 views)
Brain Res (ISSN: 0006-8993), 2005; 1047(1): 30-37.
Impact Factor: 2.296
View Export to BibTeX Export to EndNote
41 Records (39 excluding Abstracts).
Total impact factor: 199.539 (190.668 excluding Abstracts).
Total 5 year impact factor: 182.882 (173.69 excluding Abstracts).
Total impact factor: 199.539 (190.668 excluding Abstracts).
Total 5 year impact factor: 182.882 (173.69 excluding Abstracts).
647 views. Last view on Tuesday 30 May 2023, 23:11:33
ibb.cnr.it
